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1 INTRODUCTION 1
1 Introdution
1.1 Reombinant protein prodution
Reombinant protein prodution plays a entral role in modern biotehnology. Every re-
ombinant protein needs an optimized prodution proess, whih diers depending on the
required features of the protein of interest and is aeted by protein-spei properties. Re-
searh and development are mainly foused on the analysis of funtion and struture of the
reombinant protein, whereas industrial protein prodution has to fous additionally on a
ost-eient proess. Important parameters for protein prodution proesses are therefore
the growth rate of the host, the omplexity and osts of the nutrition media, the strength
of the gene expression system and the orret folding of the target protein. Corret pro-
tein folding is very important, beause many eukaryoti proteins possess posttranslational
modiations suh as glyosylation, phosphorylation, aetylation and arboxylation, whih
inuene the struture and funtion of the protein. In order to ensure the orret folding
and therefore funtionality of the protein, dierent expression hosts exist, ranging from
prokaryotes to eukaryotes.
Prokaryoti prodution systems are haraterized by a rapid growth on inexpensive media
with frequently strong gene expression rates. Limited abilities of prokaryotes to modify
proteins posttranslationally and folding problems of omplex eukaryoti proteins redue
the appliability of prokaryoti expression hosts for prodution of ertain reombinant pro-
teins.
Yeast prodution systems using the eukaryoti host organism Saharomyes erevisiae
and Pihia pastoris ombine advantages of prokaryoti hosts, suh as rapid growth and
high prodution yields with harateristis of typial eukaryotes. Although glyosylation
and modiation systems exist in yeast for posttranslational modiations of reombinant
proteins, ertain limitations for orret modiation of higher eukaryoti proteins an be
enountered.
The desire of reent years for prodution of omplex proteins, in partiular antibodies and
glyoproteins, has driven the development of inset or mammalian ell prodution, as an
alternative to primitive eukaryoti protein prodution systems. The diult handling, high
osts, intensive prodution time, low growth rate, omplex media and often low produt
yields haraterize suh higher eukaryoti prodution systems. In spite of the various dif-
ferent expression systems, the inuene of the reombinant protein on the host strain an
be hardly predited, whih makes an optimization for every single reombinant protein
inevitable [12℄.
In referene to the prodution system used in this diploma thesis, the following intro-
dutional parts will fous on prokaryoti expression systems, mainly the prodution host
Esherihia oli, for pharmaeutial appliations.
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1.2 E. oli as a ell fatory
In this diploma thesis E. oli hosts were used for the integration of the reombinant genes
in the hromosome. The gram negative baterium Esherihia oli was rst identied
in the year 1885 by a German pediatriian namely Theodor Esherih. The originally
named miroorganism Baterium oli ommune, reeived the name Esherihia oli. The
baterium is widely distributed in the intestine trats of warm-blooded animals and
therefore also of humans and lives predominantly faultative anaerobe. It belongs to
the family of Enterobateriaea, beside other well-known pathogens suh as Salmonella,
Shigella and Yersinia [21℄.
The use of E. oli as laboratory strain started in the beginning of the 20th entury. E.
oli strain K-12 was isolated from the stool of a onvalesent diphteria patient in the
year 1922 and ould be used as a laboratory strain in Stanford university, beause of a
signiant stability under laboratory onditions [13℄. After elimination of the pathogeni
genes, E. oli ould be used for laboratory experiments. In the year 1944 Gray and Tatum
reported the isolation of X-ray-indued auxotrophi mutants of bateria, inluding E. oli
K-12 strain [24℄. Studies on geneti reombination followed and sine that time thousands
of mutants of E. oli K-12 strain have been produed. E. oli emerged to beome an
important model organism for geneti studies [26℄. The genome of E. oli was fully
sequened in the year 1997 and most of the 4288 genes are funtionally haraterized. The
isolation of a gene was rst realized in 1969 by Jonathan Bekwin, who isolated E. oli
gene for the enzyme β-Galaktosidase. Driven by this ahievement the geneti studies on
E. oli as laboratory strain ontinued suessfully [12℄.
Moreover E. oli developed to be a widely used organism for reombinant gene expression,
beause of the appearane of omprehensive knowledge about E. oli biohemistry and
genetis over the last entury. The prodution of reombinant proteins in miroorganisms,
is beside the prodution of mirobial enzymes and the aquisition of mirobial metabo-
lites from industrial fermentation proesses, an important eld of the pharmaeutial and
biotehnologial industry.
In 1982 the rst reombinant expressed protein for pharmaeutial purposes was approved.
Eli Lilly's rDNA human insulin opened the market for pharmaeutials produed by geneti
manipulated organisms (GMO's). The low selling prie and the large volume of prodution
were feasible, beause of a ost-eient, highly eetive and salable proess generated by
the use of E. oli as host. For the most pharmaeutial purposes, the dominant role of E.
oli as a prodution host did not hange. The missing ability of E. oli to fold omplex
proteins in their proper onformation or to attah mammalian glyosylation hains is for
many industrial produts and appliations not required. The large knowledge of E. oli's
genetis and it's geneti exibility permit ontinuous development, even though the eld
of in vivo prodution is an established tehnology [38℄.
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1.3 Reombinant protein prodution of pharmaproteins
Reombinant proteins with high moleular masses have to be produed in pharmaeutial
protein prodution proesses. Proteins produed for pharma industry range from enzymes,
suh as proteases, hormones, suh as insulin and erythropoetin (EPO), ytokines, suh as
interferons, to antibodies, inhibitors and vaines. Beause of their strutural omplexity
in ontrast to low moleular pharmaeutial substanes, it is not possible to synthesize
them hemially in a ost and work-eient way.
The traditional way to overome this problem was the isolation of pharmaproteins out of
natural soures, suh as mammalian or human tissues or human plasma. But the amount
of suh proteins is normally very low in the natural environment and therefore isolation is
onneted to a great eort. Furthermore the possible ontamination of the proteins with
pathogens harbours a great risk fator.
Prodution of pharmaproteins in genetially manipulated ells oered a way to reeive
high amounts of pathogen-free reombinant protein. The deision, whih organism to use
for suessful prodution of the pharmaprotein, depends on the omplexity of the protein.
The funtionality and the absolute human idential posttranslational modiations have
to be veried, whih makes high standards of quality ontrol neessary for eah prodution
proess [12℄.
As Esherihia oli is one of the main prodution hosts and was used in the subsequent
work, the following setions fous on E. oli expression systems.
1.4 Reombinant protein expression systems
To design an eient reombinant expression system it is neessary to keep in mind a
number of entral elements.
1.4.1 E. oli host strains
The host strain or geneti bakground for reombinant gene expression is highly important.
It is neessary that host strains are deient in the most harmful natural proteases, to avoid
reombinant protein degradation. Geneti elements, whih are relevant for the expression
system have to exist. For dierent appliations advantageous strains are available [34℄.
In this work BL21 and HMS174 host strains were used for the integration of the target
assette.
1.4.2 Transriptional promoters
To produe suient levels of reombinant protein, a strong transriptional promoter is
neessary. Basal transription in the absene of an induer is minimized by the presene of a
suitable repressor. The promoter indution an our by addition of a hemial ompound
or by generation of a thermal dierene, in ase of temperature-sensitive promoters. The
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most ommon used induer is the sugar moleule isopropyl-beta-D-thiogalatopyranoside
(IPTG) [14℄.
Beause of the high utilization of E. oli latose (la) operon for many years, many pro-
moters used to drive the transription of heterologous proteins have been onstruted from
la-derived regulatory elements. Beside the la promoter there exists a lose relative namely
laUV5, whih is less sensitive to regulation by the AMP-CRP (AMP reeptor protein).
This redued sensitivity an be enhaned by inorporation of 1% gluose in the ultivation
medium to redue AMP levels. Both la promoters are induible by IPTG and are part for
example in the most ommon used expression system : the T7 based expression system [34℄.
A ommerially available form of this T7 based system is the pET system from Novagen.
The pET expression system was rst desribed by Studier and olleagues [37℄ in the
year 1990 and sine then more than 40 dierent pET plasmids were developed and are
ommerially available. The heterologous gene expression by this system requires a host
strain lysogenized by a DE3 phage fragment, whih enodes the T7 RNA polymerase
(bateriophage T7 gene 1), under the ontrol of the IPTG induible laUV5 promoter.
Figure 1 shows the modied la operon for the expression of T7 RNA polymerase gene
1 enoded in the DE3 phage region. T7 gene 1 is transribed as the seond gene in
a biistroni mRNA. The la repressor (laI gene produt) binds to laO1, and then
interats with pseudo-operators laO2 and laO3 to prevent transription by E. oli RNA
polymerase. The induer IPTG binds to the repressor, reduing it's anity for laO1 and
thus enabling transription to our. When AMP levels are suiently high (e.g., in the
absene of gluose) the CAP/AMP omplex is formed and binds immediately upstream
from the promoter to fully stimulate transription. In the presene of gluose, CAP/AMP
is not formed and transription is redued. This is alled the gluose eet, or atabolite
repression [3℄.
A opy of the laI gene is present on the E. oli genome and in many appliations on the
expression plasmid. The laI gene is only weakly expressed and it is possible to reeive a
10-fold enhaned repression by use of the promoter mutant LaI
q
.
The expression of T7 polymerase starts, when IPTG is added and binds to the la promoter
and triggers the release of the tetrameri laI from the la operator. The transription of
the target gene, whih is under ontrol of the T7/la promoter starts subsequently after
T7 polymerase expression. T7 polymerase transribes ve times faster than E. oli RNA
polymerases, whih is about 230 nuleotides per seond in omparison to 50 nuleotides
per seond [34℄.
The T7 promoter is a 20 nuleotide sequene spei for the T7 polymerase and not
reognized by the E.oli RNA polymerases. The strong expression system leads to large
amounts of mRNA, aumulating the desired protein at levels of 30% of the total ell
protein. Drawbaks of the system are the high amounts of mRNA whih in turn ause
ribosome destrution, a produt formation rate, whih is too high for host ell apaities
and an inreased plasmid repliation, whih might altogether even lead to ell death [14℄.
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Figure 1: DE3 phage fragment enodes for the T7 RNA polymerase gene 1 under the
ontrol of the laUV5 promoter [3℄
A way to redue the stress aused by the strong T7 system, is the tuning of the expression
rate to a tolerable level for the ell. The inrease of prodution yield aused by strong pro-
moters is restrited by the short period of time through whih reombinant gene expression
an be maintained. By the limitation of the feed of induer, a titration of the repressor
moleule an be ahieved, whih leads to the establishment of a stable equilibrium between
reombinant and ellular protein biosynthesis. With this extension of the prodution phase,
the spei amount of reombinant protein an be inreased [35℄. Expression systems based
on weak promoters are used to redue the high metaboli stress on the host ell, aused
by strong promoters as the T7 promoter. The araBAD promoter, whih is induible by
the inexpensive sugar L-arabinose is an example of suh a weak promoter. The regulation
of the arabinose operon in E. oli is direted by the produt of the araC gene. The AraC
dimer an bind to three sites in the arabinose operon, O1, O2 and I. When arabinose is
missing, the AraC dimer ontats the O1 site in the promoter region and a DNA loop is
formed, shown in Figure 2 piture 2.
Transriptional repression of the araBAD promoter and the araC promoter ours through
AraC loop onformation forming, given in Figure 2 piture 2. Upon binding of arabinose
the AraC dimer hanges its onformation, binding to the O2 site is replaed by binding
to the I site at the araBAD promoter and transription by RNA polymerase initiates, see
Figure 2 piture 3. Binding of the AraC dimer to the O1 and I sites is stimulated by AMP
reeptor protein (CRP). The bakground expression from araBAD an be redued by a
gluose mediated atabolite repression [25℄. Figure 2 piture 1 shows the linear arrange-
ment of the regulatory gene araC, the operator sites and the ara operon, whih enodes for
three enzymes that are neessary to atalyze the metabolism of arabinose.
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Figure 2: araBAD promoter based expression system [4℄
1.4.3 mRNA stability
Another aspet to onsider is the stability of mRNAs in E. oli. The levels of reombinant
gene expression are mainly inuened by the eieny of transription, mRNA stability
and the frequeny of mRNA translation [14℄. A way to ontrol gene expression is the fast
deay of mRNAs, whih leads to rather unstable mRNAs in E. oli, with half-lives ranging
between 30se and 20min. The expression rate of a gene depends therefore diretly on the
stability of the inherent mRNA [34℄.
1.4.4 Translational issues
To initiate the translation of E. oli mRNAs from the translation initiation region (TIR) a
Shine-Dalgarno (SD) sequene is neessary. The SD sequene is omplementary to the 16S
rRNA of the ribosome and is loated 7± 2 nuleotides upstream from the initiation odon,
whih is most ommonly AUG. Optimal translation initiation is obtained from mRNAs
with the SD sequene 5'-UAAGGAGG-3'.
Ribosomal binding sites (RBS) inlude the SD sequene and the initiation odon and their
seondary struture is important for translation initiation and eieny is improved by
high ontents of adenine and thymine. In prokaryotes the transription and translation are
losely oupled and therefore engineering of the translation initiation region is a powerful
tool for a promoter-independent gene expression modulation [14℄. To prevent transription
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from irrelevant promoters on the plasmid or the genome, transription terminators are
plaed downstream from the sequene enoding the target gene. Transription termination
stabilizes the mRNA by forming a stem loop at the three prime end and is preferably
mediated by the stop odon UAA in E. oli [34℄.
For transription termination T7 terminators were used in this work.
1.4.5 Inlusion body formation
The proteins used in this work are fully soluble proteins, but extensive reombinant protein
prodution an lead to a phenomenon, alled inlusion body formation.
The overprodution of heterologous proteins in the ytoplasm of E. oli an often lead
to the aggregation of the proteins in amorph granules termed inlusion bodies. The
underlying mehanism is an unbalaned equilibrium between in vivo protein aggregation
and solubilization [34℄.
The struture of inlusion bodies and the mehanism of their formation are still far from
resolved. These struturally omplex aggregates often our as a stress response, when
reombinant protein is expressed at high rates. It is possible to observe inlusion body
aggregates as refratile partiles of up to 2µm3 by optial mirosopy or as eletron-dense
aggregates by transmission eletron mirosopy [16℄.
To extrat reombinant protein out of inlusion bodies, preparation proedures exist,
whih solubilize the puried aggregates in haotropi reagents like urea and guanidium
hydrohloride. To reeive the reombinant protein in a native onformation from the solu-
bilized inlusion bodies, in vitro refolding strategies are neessary. For every reombinant
protein the refolding strategies have to be optimized [16℄.
Despite the time onsuming refolding optimization for every protein [34℄, the prodution of
reombinant protein in inlusion bodies has also advantages. The easier way of separation
of the reombinant protein from the host ell proteins, the protetion of degradation and
often high yields of produt protein an make prodution proesses with inlusion body
formation useful.
1.4.6 Plasmid based expression system
As this work investigates the prodution apaities of hromosomal based reombinant
gene expression systems, it seems to be useful to overview plasmid based systems rst.
Expression plasmids are designed in an order to ahieve high gene dosage and therefore high
prodution yields. Replions, ontaining the origin of repliation (ORI) and sometimes is
ating elements, are the ColE1 or p15A replion. Plasmids repliate in a relaxed fashion
and are present at 15-60 opies per ell ranging to a few hundred opies per ell for high
opy plasmids [14℄.
The ColE1 replion is derived from the pBR322 (opy number 15-20) or the pUC (opy
number 500-700) family of plasmids, whereas the p15A replion is derived from the
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pACYC184 (opy number 10-12) plasmid. The advantages of these plasmids are, that they
are stably repliated and maintained under seletive onditions and are free of plasmid-free
daughter ells [34℄.
The problem of plasmid loss ours, when ells are ultivated at high densities or in
ontinuous proesses or when host ells arry very high opy number plasmids. A simple
way to adress this problem is to supplement antibiotis to the growth medium and take
advantage of the plasmid enoded antibioti-resistane genes, to kill all plasmid-free ells.
Drawbaks of this system are loss of seletive pressure as a result of antibiotis degradation
or ontamination of the produt or biomass by antibiotis, whih may be unaeptable
from a medial point of view [14℄.
Sine the introdution of plasmids into E. oli indues a large number of hanges, ranging
from perturbation in the mehanism of DNA repliation, transription and translation,
interation with ellular membrane and alteration of arbon and energy metabolism, it
is obvious that high opies of plasmids in order to produe high amounts of protein,
may impose a high metaboli burden on the ells. The growth rate of the host is the
most notieable funtion aeted, leading to an overgrowth of plasmid-free ells over
plasmid-bearing ells in a mixed ulture.
As soon as reombinant gene expression is indued, this negative eet on host ell
metabolism is amplied. Energy onsumption for maintaining a plasmid is only small,
ompared to the ATP amounts needed for overexpressing a gene [19℄. Strong expression
promoters, whih are desired for high reombinant protein expression, an have adverse
eets on the host ell metabolism, driving reombinant protein synthesis at the expense
of host ell protein synthesis. To yield the optimum amount of reombinant protein, the
expression rate has to be in relation to the synthesis apaity of the host ell [17℄, whih
is diult for plasmid-enoded genes.
Through the exessive onsumption of amino aids in protein synthesis of the reombinant
produt, levels of unharged tRNAs an arise, whih in turn interfere with the plasmid
repliation ontrol mehanism. As a onsequene the plasmid opy number (PCN)
inreases up to a point, where the metaboli apaity of the host is exhausted. Strong
promoters as the T7 system are very suseptible for this phenomenon, even early during
the prodution proess [23℄.
The metaboli overload, aused by high plasmid numbers per ell, leads to a dramati loss
of ell viability and auses a signiantly shortened period of produt formation and a loss
of overall produt yield.
Beause of missing alternatives plasmid based expression systems beame, despite of the
disadvantages, state of the art for prodution and isolation of reombinant proteins on a
manufatoring sale.
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1.4.7 Chromosomal integrated systems
Alternatives to the plasmid based reombinant gene expression are E. oli systems
based on hromosomal integrated target genes. Although some disadvantages of plasmid
systems, like plasmid instability or overload of the host metabolism by high opy numbers
of plasmid, ould be overome by suh hromosomal integrated systems, they are only
sparsely distributed among industrial produtions.
Progress to the development of alternatives for reombinant protein prodution was
brought about by basi researh on E. oli. Several methods for site direted hromosomal
integration of DNA sequenes, mainly for deletions or rearrangements of genomi DNA
sequenes, were established. To realize homologous reombination independently of
baterial reombinases, phage proteins, suh as the λ phage proteins Redα and Redβ [29℄
or the ra prophage proteins ReE and ReT [39℄, were used.
Homologous reombination, important for repair of DNA double-stranded breaks and
therefore for the maintenane of genomi integrity, is mainly initiated by the prokaryoti
protein ReA in E. oli. By inativation of ReA/ ReBCD pathway, alternative reombi-
nation pathways were explored. ReA/ReBCD mutants in E. oli an be suppressed by
sbA or sbBC mutations. In sbA strains, a rypti Ra prophage operon is ativated to
express ReE and ReT. ReE is a 5'-3' exonulease and ReT is a ssDNA-binding protein
that promotes ssDNA annealing, strand transfer and strand invasion in vitro [30℄.
The genes of the λ Red system were among the earliest reombination genes to be
desribed. It was found out that λ ould reombine normally in reombination-deient
reA, reB and reC mutants of E. oli, whih lead to the reasoning that λ must enode its
own reombination funtion. Three genes were found out to be important for λ enoded
reombination system. Redα or exo enodes a 5'-3' exonulease, redβ or β a ssDNA-binding
protein with annealing and strand exhange ativity and a third gene alled gam or γ
inhibits the host ReBCD reombinase.
The genes of the Red system are lustered in the PL operon, one of two λ operons ex-
pressed early in the phages transriptional program. The exo gene produt, λ exonulease
proessively degrades the 5'-ended strand of dsDNA, generating 3'-ended overhangs. β
protein binds to ssDNA, promotes renaturation of omplementary strands, and is apable
of mediating strand annealing and exhange reations in vitro. β protein forms omplexes
with λ exonulease, and modulates both its nuleolyti and reombination-promoting
ativities. The gam gene produt inhibits all of known ReBCD protein funtions by
binding [29℄.
Normally E. oli onjugational and transdutional reombination proeed through the
ReBCD pathway, in whih the funtions of reB and reC are essential. Bloking of the
pathway by mutation in either gene an indue the ReE or ReF pathway by further
mutation, leading to a restorage of reombination ability. λ strains laking the Red system
an engage in homologous reombination via any of these pathways, in ontrast to λ
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strains possessing Red system, whih drive homologous reombination independent of
baterial reombination funtion.
Red-mediated reombination proeeds via two dierent mehanisms: invasion and an-
nealing. In Figure 3 both mehanisms are shown. Reombination is initiated by dsDNA
end, whih is reseted by β-modulated λ exonulease, produing a 3'-overhang. If the
only partner available for reombination with the dsDNA end is an unbroken irular
homologous duplex, then reombination proeeds via strand invasion, and is dependent
upon the baterial ReA protein. If the partner is repliating, or has a double-stranded end
at a genetially dierent loation, then reombination an proeed by β protein-mediated
annealing, whih is ReA independent [31℄.
Figure 3: Invasion and annealing mehanism of homologous reombination mediated
by λ Red system [31℄
Expression of the genes gam, bet and exo at moderate levels under ontrol of the la
promoter from a multiopy plasmid, was found to be non-toxi to E. oli. Reombination
events between non-repliating homologs were found to be promoted at high levels.
Furthermore Red system an be used for reombination of the baterial hromosome and
linear dsDNA introdued into the ell via eletroporation [29℄. Beause of the presene
of intraellular exonuleases, that degrade linear DNA in most bateria strains, mutants
laking exonulease V of the ReBCD reombination omplex were used for integration of
linear DNA into the hromosome [18℄.
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Red system was shown to work in dierent baterial strains for gene replaements, suh as
Salmonella or enteropathogeni and enterohemorrhagi E. oli [28℄ and was also eiently
used for DNA engineering in embryoni stem ells of mie [11℄.
These systems were mainly based on homologous reombination between DNA segments
with idential sequenes of several hundred bases. As a need for better geneti engineering,
reombination of short homologous sequenes was established. As demonstrated by Zhang
and oworkers homologous reombination either based on the ReET or the Red system
worked well for PCR-generated linear DNA speies and plasmids with only 60 bases of
homologous sequenes. Drug resistane genes anked by plasmid homologous sequenes
were generated by PCR and replaed after homologous reombination plasmid sequenes,
therefore generating a new plasmid [39℄.
Datsenko and Wanner used λ Red system for homologous reombination between PCR
generated homology assettes and the E. oli hromosome, sharing only 36 bases of
homology. Red genes gam, bet and exo were plaed on a low-opy plasmid under the
ontrol of the arabinose induing promoter ParaB. With this approah 13 dierent E. oli
disruption mutants were generated. E. oli genes were substituted by resistane genes
anked by FRT (FLP reognition target) sites, whih were amplied with PCR primers
that were homologous to regions adjaent to the gene to be inativated. After seletion of
the mutants, they eliminated the resistane gene by using a helper plasmid expressing the
FLP reombinase, whih exised the diretly repeated FRT sites anking the resistane
gene. The use of temperature-sensitive replions on Red plasmid and FLP helper plasmid
oered an easy way of uring baterial ells from helper plasmids by a temperature-shift
to 37°C [18℄.
The hromosomal integration proedure used in this work is based on the λ Red system
and was developed based on the results ahieved by Datsenko and Wanner [36℄. The
homologous reombination ours between 300bp homologies on the Tn7 lous of E. oli
host strains. The Tn7 site originates from a large transposable element with 14kb in size,
whih enodes resistane to the antibiotis trimethoprim, spetinomyin and spreptomyin.
Unusually Tn7 transposes from episomal elements to a single site within the hromosome
of E. oli at the high frequeny of 10−2/ell per generation. All transpositions of Tn7 to
the E. oli hromosome whih have been haraterized, took plae at a single site and in
an unique orientation near minute 82 of the hromosome. As more detailed analysis show,
lies the Tn7 unique site between the genes glmS and phoS, more preisely in the glmS
transriptional terminator [22℄.
1.5 Tandem gene genome integration
The integration of two idential produt genes into the host hromosome, whih was done
in this work, was aompagnied by unertainties based on the appearane of tandem
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repeat instabilities.
Reports dealing with tandem repeat instability give reason to assume the ourrene
of deletion or dupliation events between tandem repeated genes [33℄. Gene deletion of
repeated sequenes was reported to at ReA-dependently and ReA-independently, in
both ases it is a problem of repliation fork blokage during DNA repliation [27℄. Large
repeats of several hundred base pairs were observed to delete at high frequenies and
deletion rate dereases exponentially as the distane between the homologies inreases
[15℄.
1.6 Bioreator ultivations
A main part of the underlying diploma thesis was the observation and analysis of the on-
struted tandem gene assettes integrated in the host strain hromosome in the ourse of
a shake ask and a bioreator ultivation.
Bioreator ultivations were run in a fed-bath mode. What is most important for biorea-
tor ultivations are tightly ontrolled onditions all over the ultivation broth. Maintaining
of the proess onditions for an optimal growth, is ensured by the observation of parame-
ters, suh as the temperature, the pH and the oxygen onentration by on-line probes and
the subsequent regulation of the parameters. The determination of the growth rate of the
baterial ells during the ultivation, as well as the produt yield and the produt forma-
tion rate were performed to reeive information about the funtionality of the integrated
assettes and the host ell metabolism during reombinant protein prodution.
1.6.1 Growth of miroorganisms
To desribe the growth harateristis of miroorganisms a bath ultivation is very useful.
Beause of the exponential growth of miroorganisms, the biomass as a funtion of the time
is presented in a semi-logarithmi way. A bath ultivation is based on a dened volume of
media, whih gets inoulated by a small amount of bateria. The miroorganisms start to
proliferate and to onsume substrate and at the same time metabolites get enrihed. When
the substrate is onsumed, ell growth is redued until it is stopped at a ertain time point.
The growth urve an be divided in ertain phases. The "lag" phase starts immediately
after inoulation and is haraterized by no inrease in biomass. The ells use this phase to
adapt to the new environment. After nishing this proess the exponential ell proliferation
starts, whih is presented in the semi-logarithmi graph as a linear asent. In the end of
this phase the asent of biomass is redued, beause of a substrate limitation or metabolite
inhibition. This is the phase of redued growth. The last phase is the stationary phase, in
whih the biomass onentration remains onstant. The veloity of ell growth is as high
as the veloity of ell death [20℄.
Equation 1 shows the inrease of biomass onentration (X) as a funtion of the time t for
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the exponential phase and the phase of redued growth. µ indiates the spei growth
rate, whih an be onsidered onstant µ = µmax for the exponential phase.
dX
dt
= µX (1)
The integration of equation 1 with the boundary onditions X(t = 0) = X0 results in
equation 2.
X = X0 · e
µmaxt
(2)
The doubling time tD for the exponential phase is dened as:
tD =
ln2
µmax
(3)
1.6.2 Bath and fed-bath
In bath ultivation substrates or nutrients are not added during the baterial growth.
The available substrates are given in the bath medium and substrate turnover results in
biomass and produt. The proess is ended when ells stop to grow, whih an be beause
of missing substrates or aumulated metabolites.
When the bath is used up, ontinuous feeding of medium starts. The addition of the feed
an be followed by dierent strategies, for example by exponential algorithm to provide a
onstant growth rate [12℄.
1.6.3 Produt formation
Knowledge of the kinetis of produt formation is essential for proess operation. On the
one hand for mirobial proesses on the industrial sale, produt yields are more important
to know than the amount of biomass and on the other hand it is essential to know formation
rates of inhibiting metabolites.
A orrelation between the produt formation rate and the growth kineti is presented in
equation 4 [20℄, when the substrate of the bath ulture is onsumed.
dP
dt
= (YPXµ)X (4)
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1.6.4 Produt yield and turnover oeients
Produt yield and turnover oeients dene a ratio between the onsumption of sub-
strates and the prodution of biomass and other produts, without knowing the exat ell
metabolism. Table 1 shows the most important produt yield and turnover oeients [12℄.
Symbol Denition
YXS produed biomass in referene to onsumed substrate
YPS produed produt in referene to onsumed substrate
YPX produed produt in referene to produed biomass
YXO produed produt in referene to onsumed oxygen
RQ produed arbon dioxide in referene to onsumed oxygen
Table 1: Typial produt yield and turnover oeients [12℄
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2 Aim of the work
The aim of the work is to determine the limits of reombinant protein expression in hromo-
somal enoding E. oli systems. Systems with an integrated single opy of the reombinant
gene have already shown high produtivity and stability, but the ellular apaities were
not fully exploited.
In order to investigate the expression limits of hromosomal integrated hosts, gene on-
struts ontaining two opies of the produt gene will be generated. GFP and SOD, two
reombinant model proteins, will be integrated into E. oli (BL21 and K-12) hosts using
homologous reombination based protools.
The obtained gene onstruts will be tested and haraterized in shake ask and bioreator
ultivations. For evaluation of tandem gene systems, the obtained results will be ompared
with systems with an integrated single opy and with plasmid based systems.
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3 Materials and Methods
3.1 Baterial strains
As loning host E. oli strain DH5α was used and E. oli reA(-) K12 strain HMS174(DE3)
or E. oli B-strain BL21(DE3) provided by Novagen were used as expression hosts. Both
strains are lysogens of λ DE3 prophage, and arry a hromosomal opy of the T7 RNA
polymerase gene under ontrol of the laUV5 promoter. Therefore both strains are suitable
for protein expression using T7 or T7 la promoters.
3.2 Plasmids and linear assettes
On all expression assettes the desired gene is under ontrol of the ombined T7/la pro-
moter ontaining a 25bp la operator sequene for a tight ontrol of the strong T7 expression
system. Termination is provided by the T7 terminator. Chlorampheniol resistane was
amplied with it's own promoter from pLysS (Novagen). Chlorampheniol resistane gene
enodes a hlorampheniol aetyltransferase (CAT).
Starting plasmids for loning proedure of linear assettes are pBKS(-) vetors arrying the
Tn7::CAT:T7pGFP inserted at NotI and KpnI restrition sites in the multiple loning site.
GFPmut3.1 starting plasmids are shown in Figure 4. hSOD plasmids were onstruted
in the same way, starting with the same starting plasmids, solely GFPmut3.1 replaed by
hSOD.
Figure 4: Starting plasmids: pBKS(-) with linear assettes Tn7::CAT:GFP or
Tn7::GFP:CAT
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3.3 Model proteins
3.3.1 GFPmut3.1
The green uoresent protein (GFP) is a 26,9 kDa protein, onsisting of 238AA and was
originally isolated from the jellysh Aequorea vitoria. It uoreses green when it is exposed
to blue light, whih means that it has a major exitation peak at wavelength 395nm and
a minor one at 475nm, whereas the emission peak lies at 509nm. The mutational form
GFPmut3.1, whih was used, is an FACS optimized variant with substitutions S65G and
S72A. It has an improved folding and exitation at 488nm and is a highly soluble brightly
uoresing protein. The exitation and emission spetra of GFPmut3.1 dier from the
spetra of the wild type form and uoresene is desribed to be improved about 100-fold
in omparison with wtGFP [32℄.
3.3.2 rhSOD
Human Superoxide (Cu/Zn) dismutase is a protein atalyzing the redution of two free
oxygen radials to hydrogen peroxide. In the human body it funtions as an important
antioxidant defense in nearly all ells exposed to oxygen. It's moleular weight is 32kDa and
it is a dimeri moleule whih onsists of two idential subunits (153AA eah), ontaining
a opper and a zin atom in the ative enter. When it is expressed reombinantly in
baterial hosts, it is soluble and forms no inlusion bodies.
3.4 Cloning methods
The designated linear assettes with two gene opies of GFPmut3.1 or hSOD were reated
by ligation of two PCR-produts. All primers used were designed by the aid of SeqMan
and pDraw32 and ordered by eurons MWG GmbH. To reate the tandem gene linear
assettes two PCR reations were designed and after puriation of the PCR produts,
both onstruts were digested and ligated.
Length of the ligated onstruts was veried by agarose gel eletrophoresis and DNA was
sequened to exlude possible mutations. DNA sequening samples were sent to AGOWA
GmbH aording to the instrutions given for barode sequening [2℄.
3.4.1 PCR (Polymerase hain reation)
PCR is the most ommon method to amplify spei DNA sequenes. Starting point is
usually a double-stranded DNA (dsDNA). The two spei primers (oligonuleotides spe-
i to the 3' end of the target DNA segment), dNTPs and a thermostable polymerase (e.g.
Novagen KOD-XL) are added in great exess. KOD XL polymerase was used to amplify
long DNA sequenes with a high delity. MBI taq polymerase (MBI Fermentas) was used
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to sreen olonies from agar plates or liquid ultures, as well as for Mini Preps, to determine
the integration of the assette of interest. All PCR reations were run with Master Cyler
Gradient (Eppendorf). Dierent PCR set-ups were performed to amplify DNA produts
using dierent templates, primers, DNA polymerases and temperature proles. PCR set-
ups for KOD-XL PCR and Taq polymerase PCR are given in appendix in tables 14, 15,
16 and 17. All primers were used (Appendix: table 13) at a onentration of 10pmol/µl;
template DNA had an approximate onentration of 5ng for one reation.
3.4.2 Restrition digestion
DNA restrition digests were used for preparing DNA fragments (PCR produts) for
ombining or for ligation of a vetor with an insert. Restrition endonuleases are
enzymes, whih are lassied into three groups (type I, II and III) based on their subunit
omposition, their leavage position, their sequene-speity and ofator-requirements.
Type I enzymes are omplex, multisubunit and a ombination of restrition and mod-
iation enzymes that ut DNA far from their reognition sequenes. Beause of their
missing prodution of disrete restrition fragments or distint gel-patterns they have
little pratial value. Type III enzymes are also a large ombination of restrition and
modiation enzymes, but they leave outside of their reognition sequene and lead rarely
to omplete digests and are therefore as useless for laboratory work as type I enzymes.
Type II enzymes reognize speially 4-8bp sequenes and leave both DNA strands
lose to or within their reognition sequenes. Beause they produe disrete restrition
fragments, they are the only lass used in laboratory for DNA analysis and gene loning.
Many restrition enzymes leave asymmetrially within the reognition sequene and
provide "stiky ends". If the ends of the insert fragment and of the vetor are ompatible
they an be easily ligated. Additionally restrition endonuleases an leave DNA strands
in a way to produe "blunt ends".
Used restrition enzymes and supplied 10x buers were used from NEB and were stored at
-20°C. Normally 2µl of enzyme were used for a 50µl reation, but enzyme ativities may
dier and must be onsidered. Addition of 5µl of 10x buer and 1µg of DNA for 50µl
reation volume ompleted the reation and inubation was performed for 2h at 37°C and
300rpm on a heating blok (Eppendorf). If neessary enzyme inativation was maintained
by inubation on 65° or 80°C for 20min, whereas temperature and time depended on the
enzyme. Double digestions with two enzymes were performed in NEB buer, whih gives
both enzymes highest ativity [6℄.
3.4.3 Agarose gel eletrophoresis
To determine the length and purity of DNA moleules gel eletrophoresis methods are
used. Beause eah nuleotide in a nulei aid moleule arries a single negative harge,
the nulei aids move to the positive eletrode in an eletri eld. To separate these
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moving nulei aids by their size, porous gels formed by dilute solutions of agarose, whih
is a polysaharide isolated from seaweed, are used. These DNA separation methods are
used for both analytial and preparative purposes. Beause DNA bands are invisible on the
gel, DNA has to be exposed to the dye ethidium bromide, whih interalates into nulei
aids and uoreses under ultraviolet light [10℄.
For analytial gels, as well as for preparative ones, 1.5% agarose were dissolved in 1x TAE
buer (tris-aetate buer at pH = 8, 0 with EDTA that sequesters divalent ations) and for
120ml gel 3µl ethidium bromide were added. Analytial gels were run at 130V and 500mA
and preparative gels at 90V and 500mA. As moleular marker O'GeneRuler
TM
DNA ladder
Mix (MBI fermentas), ladder sizes shown in appendix gure 21, was used.
3.4.4 DNA puriation
Gel extration and PCR puriation
For extration of appropriate DNA bands from an agarose gel or for the puriation of PCR
produts after PCR reation, Wizard SV Gel and PCR Clean-Up System (Promega, Cat.
No: A9281) was used. With this kit DNA fragments of 100bp to 10kb an be extrated from
agarose gels in Tris aetate (TAE) buers. The puriation of PCR produts is ommonly
used for remove exess nuleotides and primers, to make PCR produts ready for further
use. The Clean-Up system is based on the ability of DNA to bind to silia membranes in
the presene of haotropi salts. The exised band after eletrophoresis or the PCR produt
are dissolved in the presene of guanidine isothioyanate. The isolation of DNA ours by
miroentrifugation to fore the dissolved gel slie or PCR reation through the membrane
while simultaneously binding the DNA on the surfae of the silia. After washing the DNA
fragment or PCR produt, the DNA is eluted in water [9℄.
Plasmid preparation
To isolate and purify plasmid DNA out of baterial overnight ultures, the Wizard Plus SV
Minipreps DNA puriation System (Promega, Cat. No: A1330) was used. The system an
isolate plasmids less than 20000bp in size from Esherihia oli hosts and delivers puried
plasmids ready for further manipulation. Isolation of plasmids was performed from 1-
10ml overnight ultures, ells were entrifuged at 4000rpm for 5min and the supernatant
was disarded. Cells were resuspended in 250µl ell resuspension solution and mixed by
invertion, not by vortexing to prevent shearing of hromosomal DNA. Afterwards 250µl ell
lysis solution were added, inverted several times and inubated until the ell suspension
leared. In the next step 10µl alkaline protease solution was added and inubated for 5min
after inverting several times. Alkaline protease inativates endonuleases and other proteins
released during the lysis of baterial ells that an aet the quality of the isolated DNA.
The reation is stopped by adding 350µl of neutralization solution. The baterial lysate is
entrifuged for 10min at 14000rpm. Plasmid DNA puriation ours by binding of DNA
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to silia membranes during miroentrifugation and washing several times in 95% ethanol
until plasmid DNA is eluted in water [8℄.
3.4.5 Quantiation of DNA
To determine DNA onentrations of PCR produts, Mini Preps or gel extrated DNA,
the NanoDrop ND-1000 Spetrophotometer was used. The NanoDrop ND-1000 is a full-
spetrum (220-750nm) spetrophotometer that an measure 2µl samples of DNA. By sur-
fae tension the sample is hold in plae and does not need to be plaed in a uvette. It is
possible to measure nulei aid samples up to 3700ng/µl (dsDNA) without dilution [5℄.
3.4.6 Ligation
For ligation of restrition enzyme digested PCR produts or vetors and inserts T4 DNA
ligase was used (NEB, Cat.No:M0202S). T4 DNA ligase atalyzes the formation of a phos-
phodiester bond between juxtaposed 5' phosphate and 3' hydroxyl termini in duplex DNA
or RNA. The enzyme joins blunt end and ohesive end termini as well as repairs single
stranded niks in duplex DNA, RNA or DNA/RNA hybrids. Ligations were performed
overnight at 16°C by adding 1µl T4 DNA ligase, 2µl T4 ligase buer, the appropriate
amounts of PCR produts or vetor and insert DNA and H2O to 20µl reation volume.
For inativation of T4 ligase inubation 10min at 65°C an be performed [7℄.
3.4.7 Isopropanol preipitation of DNA
To remove working buers, e.g. after ligation, or for higher onentration of DNA iso-
propanol preipitation an be used. The preipitation is mediated by high onentrations
of salt (sodium aetate) and the addition of isopropanol. 1/10 volume 3M sodium a-
etate and 0.6 fold volume of isopropanol were added, mixed and inubated 30min at -80°C.
Preipitated DNA was entrifuged for 30min at 4°C at 13000rpm in a minientrifuge and
the supernatant was disarded ompletely. DNA was washed with 1ml 70% EtOH and
entrifuged for another 5min at 4°C. Supernatant was disarded and the DNA pellet om-
pletely dried at room temperature (RT). DNA was dissolved in 10-20µl RO-H2O and stored
at -20°C for further use.
3.5 Transformation of DNA into baterial ells
Transformation desribes the geneti alteration of a ell resulting from the uptake and
expression of foreign geneti material (DNA). To overome the problem that only 1% of all
baterial speies are naturally apable of taking up DNA, baterial ells have to be treated
to beome ompetent. To make ell walls permeable for DNA eletroporation an be
performed. By appliation of an external eld the eletrial ondutivity and permeability
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of the ell wall is signiantly inreased, so that DNA an be taken up. To avoid the
phenomenon of aring, the salt ontent of the DNA solution and the baterial suspension
should be redued to a minimum.
3.5.1 Preparation of eletroompetent ells
Cells to beome eletroompetent were inoulated in 10ml LB (medium omposition given
in 7.1.3) with appropriate antibiotis and inubated overnight. On the next day ells were
diluted 1:100 in fresh LB medium with antibiotis and ells were inubated until they reah
an OD600 = 0.6. Cells were plaed on ie and 50ml ell suspension were entrifuged for
5min at 4000rpm and 4°C (Bekman Coulter Avanti J-25 Centrifuge, rotor JA-10.500).
The supernatant was disarded and the ell pellet resuspended in 1ml ie-ooled RO-H2O.
The ell suspension was transferred into 1,5ml Eppendorf tubes and entrifuged for 2min
at 13000rpm at 4°C in a minientrifuge. Supernatant was disarded and ells were washed
with H2O another three times in the same way as already desribed. In the nal step
80µl ie-ooled H2O was plaed on the baterial ell pellet and ells were left on ie until
eletroporation.
3.5.2 Eletroporation
20-600ng of DNA were put to the 80µl ie-plaed eletroompetent baterial ells. Baterial
ells and DNA were put into an eletroporation uvette and put into the eletroporation
apparatus (Bio-Rad gene pulser), whih was set to deliver an eletrial pulse of 25µF
apaitane, 2.5kV and 1000Ohm resistane. After eletroporation bateria were put into
900µl SOC medium (medium ingredients given in 7.3.1) and inubated for 1h at 37°C
and 300rpm. 200µl and 800µl of the baterial suspension were plated on LB agar plates
ontaining the appropriate antibiotis. After drying the plates were inubated overnight
on 37°C.
3.6 Genome integration methods
3.6.1 λ-Red reombination system
Chromosomal integration
PCR generated linear integration assettes were heked by sequening before they were
used for genome integration. One olony of MG1655 bateria was piked and inoulated
in LB + Amp + 0.2% gluose and were grown overnight at 37°C. Bateria were inoulated
1:100 in LB + 0.2% arabinose and in LB without arabinose as negative ontrol on the next
day and grown on 30°C until they reahed an OD600 of 0.4 to 0.6. Bateria were aliquoted
in 50ml Falons and entrifuged at 4°C and 10000rpm for 5min. Supernatant was disarded
and ell pellet washed four times with 1ml ie-ooled H2O. After the last washing step, the
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ell pellet was resuspended in 80µl ie-ooled H2O and linear DNA onstruts were added
at a onentration of 200, 400 and 600ng. Eletroporation was performed as desribed in
3.5.2.
After 1h inubation at 37°C 500µl of the baterial suspension was plated on LB agar plates
and hlorampheniol and the other 500µl were inubated overnight at 37°C and 300rpm
and plated on the next day. Positive olonies were sreened by Taq-sreening PCR, see for
more detailed information subsetion 3.4.1 and appendix tables 16 and 17, and sequened
to verify the right integration.
The genome integrated lones with the right sequene were ured from the pKD46 plasmid
by growing olonies at 42°C and streaked out on LB-Amp plates to sreen for ampiillin
sensitive lones. If lones were still ampiillin resistant, lones were grown again on 42°C
overnight until they beame ampiillin sensitive.
Phage lysate preparation
MG1655 donor strain with the genome integrated assette was grown overnight on LB
ontaining 5mM CaCl2 and then diluted 1:100 into 5ml LB medium ontaining 5mM
CaCl2. 0, 50, 100 and 200µl of a high titer P1 lysate was added to the ulture and shaked
at 37°C until lysis oured. Cultures have to be heked for lysis hourly. Then 100µl
hloroform was added, mixed and ell debris were removed by entrifugation at 3000rpm
for 10min. The supernatant (phage lysate) was stored at 4°C in a light safe loation.
P1 vir transdution
300µl of an overnight ulture of the aeptor strain, either re(+) E. oli strain BL21(DE3)
or the E. oli strain HMS174(DE3) ontaining a temperature sensitive helper plasmid
(pTSA19reA), whih was inubated in 5ml LB medium with 5mM CaCl2, was mixed
with 100µl phage lysate. Ratio of ells to phage partiles should be 1:1 to 1:10. Controls
are phage only and aeptor strain only reations, to see if the phage lysate is ontaminated
with the donor strain.
After a stati inubation of exatly 25min on 30°C (for HMS174(DE3) with pTSA19reA) or
on 37°C (BL21(DE3)), 5ml LB medium ontaining 10mM NaCitrate were added. Cells were
entrifuged at 3000rpm for 15min and the pellet was resuspended in 1ml LB medium with
10mM NaCitrate again. For allowing expression of antibioti resistane genes, ells were
shaken 1h at 30°C (37°C) and then spread on seletive media. Curation of HMS174(DE3)
strain from pTSA19reA helper plasmid was performed by inubation on seletive plates
at 42°C and sreening for ampiillin sensitive lones. Positive lones were again heked by
Taq sreening PCR and sequening.
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3.6.2 Quik & Easy E. oli Gene Deletion Kit
HMS174(DE3) and BL21(DE3) E. oli strains were transformed with pRedET plasmid
(with ampiillin or tetrayline resistane gene) aording to the desription given in 3.5.1
and 3.5.2. Figure 5 shows the vetor map of pRedET plasmid.
After transformation ells were inubated for 70min at 30°C and 300rpm, with regard
Figure 5: pRedET plasmid of Quik & Easy E. oli Gene Deletion Kit [1℄
to the temperature sensitivity of the pRedET plasmid. Inubation overnight at 30°C
followed on LB agar plates with ampiillin or tetrayline, depending on the resistane
of the transformed plasmid. The reeived olonies were restroken on additional LB agar
plates (+ antibiotis) and frozen in ryostoks at -80°C.
For genome integration a olony from the HMS174(DE3) pRedET-Amp or pRedET-Tet or
BL21(DE3) pRedET-Amp or pRedET-Tet was piked and inoulated in LB + antibiotis
at 30°C overnight. On the next day bateria suspension was diluted 1:100 in LB medium
and antibiotis and inubated until the ells reahed an OD600 = 0.3. 20% L-arabinose
solution was added to a nal onentration of 0.4% L-arabinose. 5ml bateria suspension
were left without addition of L-arabinose for negative ontrol of the experiment. Cells
were inubated for 1h at 37°C to indue transription of reombinational genes bet, exo
and gam. 5ml aliquots of the bateria suspension were entrifuged at 4°C and 10000rpm
for 5min and ells were made ompetent as desribed in 3.5.1 and 3.5.2.
Figure 6 shows the mode of ation of the ra prophage genes ReE and ReT, respetively
the λ Red genes Redα and Redβ. 5'-3' exonulease ReE or Redα start to degrade
the double-strand linear, leaving behind a single-stranded DNA. ReT or Redβ are
single-strand binding proteins and bind immediately to the produed single strand. After
joint moleule formation, DNA repliation an our.
Inubation after transformation was for 3h at 37°C and 300rpm and afterwards ells were
plated on LB agar plates with hlorampheniol. Positive olonies ourred on the next day
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Figure 6: Funtion of ReE/ Redα and ReT/ Redβ in homologous reombination [1℄
and were sreened by Taq sreening PCR (see subsetion 3.4.1 and appendix tables 16 and
17). Positive olonies were sequened and restroken on LB agar plates with hlorampeniol.
Clones with aurate sequenes were used for further experiments.
3.7 Preparation of ell banks
3.7.1 Researh ell bank (RCB)
A single olony of a new strain was piked from a seletive agar plate and ultivated in 3ml
seletive LB-medium. At OD600 = 3 one volume of this ulture was well mixed with one
volume sterile 87% glyerol and transferred into ryo-tubes for storage at -80°C.
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3.7.2 Master ell bank (MCB)
The orresponding E. oli ulture was ultivated an a solid seletive medium. A single
olony was piked and aseptially transferred to a ask lled with 40ml M9-ZB medium
(see appenix table 3) with appropriate antibiotis. After overnight inubation, 80ml M9-ZB
with appropriate antibiotis were inoulated with overnight ulture at an OD600 = 0.150
and after 30min of inubation at 37°C and 180rpm, 40 ml of the ell ulture were transferred
to a new sterile 250ml ask (=referene ontrol). A third 250ml shake ask whih had
been lled with 40ml sterile medium without antibiotis was inubated as a sterile ontrol.
OD600 of samples taken from the referene ask was measured during the ultivation. At
OD600 = 3 1ml of the WCB was taken for Koh testing. The remaining ell suspension was
mixed with 1 volume of 87% glyerol and lled into ryo-vials for storage at -80°C. Koh
plate testing was done as desribed in 3.9.2.
3.8 Cultivation in shake asks
Shake ask experiments were started with an overnight ulture (bateria grown in 40ml
semisyntheti medium) to inoulate 400ml semisyntheti medium (see for detail ompo-
sition appendix table 4) in 2l shake asks to start ell ultivation at OD600 = 0.150 at
37°C and 180rpm. At OD600 = 2 reombinant protein expression was indued by 1mM
IPTG (IPTG stok solution: 0.3g in 3ml RO-H2O, sterile ltered). Samples were taken
shortly before indution, 30min, 60min, 120min, 180min and overnight after indution. For
the determination of reombinant protein onentration (rhSOD, GFPmut3.1), 1ml sample
was taken and entrifuged for 10min at 4°C at 13000rpm (Eppendorf Centrifuge 5414R).
The supernatant was disarded and the pellet was dried and frozen at -20°C. OD600 and
o-line uoresene (for GFPmut3.1) were measured. From sample 180min post indution
a Koh was performed to determine ells arrying the genome integrated assette with the
resistane gene.
3.9 Fed-bath ultivation in bioreators
To ensure dened ultivation onditions and to minimize build-up of metaboli by-produts
(e.g. aetate) during the proess, fed-bath ultivations were performed at a onstant
growth rate of 0.1 h−1. Cells were grown in a 20l omputer-ontrolled bioreator (MBR;
Wetzikon, CH) equipped with standard ontrol units. For inoulation of the proess, a
deep-frozen (-80°C) working ell bank vial was thawed and 1ml (OD600 = 1) was transferred
aseptially to the bioreator. Bath and feed-media are given in appendix table 5.
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3.9.1 Cultivation onditions
Temperature
Temperature was measured with a Pt100 temperature probe and maintained at 37°C ±
0.5°C.
pH
Calibration was performed with ommerially available buer solutions. pH was maintained
at a set-point of 7.0 ± 0.05 by addition of 25% ammonia solution (ACROS Organis).
pO2
Calibration of the Clark probe was performed after sterilisation at 800rpm and 37°C using
N2-gas or an O2-simulator (Mettler Toledo) for 0% saturation and ompressed air for 100%
saturation. The dissolved oxygen level was maintained above 30% saturation by stirrer
speed (800 to 1200rpm) and aeration rate ontrol.
Fed-bath ultivation
The substrate was added to the bioreator following an exponential prole in order to
keep the growth rate at the desired value. As equation 5 shows, the key parameter for the
exponential feed regime was the amount of biomass present in the bioreator after the bath
phase (X0), sine this biomass had to be provided with an adequate amount of substrate.
Feeding was initiated at the end of the bath when baterial dry matter reahed a value of
30g in 4l.
X1 = X0 · e
µmaxt
(5)
Equation 6 shows the orrelation between the amount of feed media required to produe
the biomass present at the end of the bath phase (S0), the yield oeient (YX/S), the
substrate onentration (CS) and X0.
S0 =
X0
YX/S · cS
(6)
The alulation of the amount of media S required in a time interval t, when biomass X
was produed at a onstant µ, is dened in equation 7.
∆S = S0 · (e
µ·∆t
− 1) (7)
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The media tank was plaed on a balane to alulate Starget permanently after starting the
exponential feed regime. Based on the initial weight of the media tank, an exponentially
dereasing set point urve was alulated, shown in equation 8.
Starget = Sstart −∆S (8)
A PID ontrol algorithm adjusted the pump speed aordingly this set point urve.
Addition of antifoam
To avoid foaming 1ml antifoam solution (Glanapon 2000, Bussetti, Vienna) was added per
kg feed media .
Indution of reombinant protein prodution
Indution was performed using a onventional single pulse of IPTG diretly into the biore-
ator. To obtain a fully indued system, the supplied amount of IPTG was alulated to
yield a onentration of 1µmol IPTG at the end of the proess.
Cultivation media
A KH2PO4/K2HPO4 ∗ 3H2O buer provided the required buer apaity and served also
as P and K soure. The other omponents were added to the media in relation to the gram
baterial dry matter to be produed, for detailed information see table 5 in the appendix.
Yeast extrat was added to the bath medium to aelerate initial growth. Feed medium
was prepared aording to the amount of biologial dry matter to be produed during the
feeding phase. Cu/Zn solution had to be added to provide intat rhSOD formation.
3.9.2 O-line analysis
For o-line analysis 15-20ml of ulture broth were taken asepti out of the bioreator and
used for following oine analysis:
Optial density (OD600)
Optial density was measured at wavelength λ = 600 with a spetrophotometer (Amersham
Biosienes Ultrospe 500 pro, Pharmaia Bioteh Ultrospe 1000E). Dilution of samples
was performed in RO-H2O to reah linear range (0.1-0.6).
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Cell dry weight (CDW)
Cell dry weight (CDW) was determined by entrifugation of 10ml of ell suspension for
10min at 5000rpm (Heraeus Labofuge 200) and washing the ells with 5 ml RO-H2O (re-
suspension and entrifugation). Cells were resuspended and transferred to a pre-weighed
beaker, whih was dried for 24 h at 105 °C and reweighed. To alulate total CDW, the
volume of ultivation broth was alulated by summarising initial bath volume, feed media
and base added and subtrating the volume of the samples taken.
Samples for protein quantiation
To obtain equal ontents of CDW per sample for ell desintegration, volumes ontaining
an estimated CDW of 1mg were transferred to an Eppendorf tube and entrifuged for
10min at 4°C. The supernatant was disarded and probes were stored at -20°C until ell
desintegration, see 3.10.
Koh plating
In order to observe the ells ontaining the linear assette during the proess and to de-
termine the stability of the ultivation, baterial ells were ultivated and olony forming
units (CFU) were ounted after 24h. Cells were plated at 10−7, 10−8 and 10−9 dilutions on
nutrient broth agar plates and on plates ontaining 25mg/l hlorampheniol.
O-line uoresene
The uoresene of ells was measured using the miroplate reader SPECTRAmax Gemi-
niXS and SOFTmax PRO software (Moleular Devies). 100µl of ulture broth and 100µl
of ulture supernatant were measured in well san mode of density 3x3 (9 points per well)
in blak, at bottom plates with transluent bottom (Costar). Exitation wavelength was
set to 488nm and emission wavelength to 530nm for GFPmut3.1. For GFPmut3.1 detetion
the best signal to noise ratio was obtained using a 515nm ut-o lter.
For alulation of the spei ellular uoresene, the uoresene of the supernatant had
to be subtrated from the uoresene of the ulture broth and be divided through the
BDM.
FACS analysis
Total Cell Number (TCN) and perentage of dead ells (DC) were determined using ow
ytometri methods. All measurements were performed with a FACSCalibur ow ytometer
(four-olor system; Beton Dikinson), equipped with an air-ooled laser providing 15mW
at 488nm and the standard lter setup. For aquisition and analysis of data, the CellQuest
software pakage (version 4.1, Beton Dikinson) was used.
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Forward light satter (FSC), right-angle light satter (side satter; SSC), and uoresene
were olleted as pulse height signals (four deades of a logarithmi sale). Side light
satter (SSC) served as the primary detetion parameter (threshold value 125). In addition,
software disriminators were set on side satter light signal to further redue eletroni and
small partile noise. Disrimination of dead ells was done via staining with propidium
iodide, while total ell number was determined via ratiometri ounting. Samples were
spiked with a known amount of uoresent ounting beads (Beton Dikinson, USA) so
that the absolute ell number ould be bak-alulated.
Viability staining was performed with a ombination of 3 uoresene dyes: Bis-oxonole
(BOX), whih is lipophili and anioni and is aumulated if the membrane is depolarised;
ethidiumbromide (EB), whih binds to DNA and is slightly better membrane-permeable
than PI and is atively exluded; propidiumjodide (PI), whih binds to DNA and is almost
not membrane-permeable, binds to DNA if the membrane is destroyed. A sample of the
ulture broth was taken and diluted if neessary to a onentration of approximately 108
to 109 ells/ml. From this dilution, 20µl were transferred to 400µl of fresh-made dye
solution (PI 5µg/ml, EB 10µg/ml, BOX 10µg/ml, all diluted in PBS + 0.1 mM EDTA).
Dye solutions were stable for approximately 12h. Diretly before measurement, the FACS
was rinsed for 15se with the sample to ensure that no residues of previous samples were
present.
3.9.3 On-line measurement
O2/ CO2
To measure the onentration of CO2 (%) and O2 (%) in the exhaust gas a gas analyser
system using gas analyser modules from ABB In were used. CO2 was measured by
infrared spetrosopy (analyser type Uras), while O2 was measured based on paramagneti
properties of oxygen (analyser type Magnos).
Base onsumption
The onsumption of base during the fermentation proess was reorded by deteting weight
loss of the base tank, whih was put an a balane. Base volume was alulated using the
spei density of 0.91kg/l for 25% ammonia solution.
3.9.4 Calulated values
Culture volume
To alulate the ulture volume of the ultivation proess, the initial bath volume, the
feed media and the added base were summed up and the volume of the taken samples was
subtrated.
3 MATERIALS AND METHODS 30
Growth rate
Growth rate was alulated aording to equation 9 or equation 10.
µ =
1
X
·
dX
dt
(9)
µ =
lnX1
X2
t2 − t1
(10)
Spei produt formation rate (qP)
The spei produt formation rate is dened as formation rate of desired produt related
to the average biomass present. Equation 11 shows the alulation for qP ([mg/gBDM∗h℄)
between two measurement points.
qP =
1
X1+X2
2
·
P2 − P1
t2 − t1
(11)
Kp
Kp is the formation rate of the desired produt related to the formation rate of biomass
in non-fully growth assoiated onditions (instead of qP). Equations 12 and 13 show the
alulation of KP ([mg · 100/gBDM ℄) between two measurement points.
KP =
dP
dt
dX
dt
· 100 (12)
KP =
P2−P1
t2−t1
X2−X1
t2−t1
· 100 (13)
3.10 Analysis of produt yield
3.10.1 SDS gel eletrophoresis
To determine if inlusion bodies are formed during the ultivation proess ell dry weight
(CDW) samples are desintegrated and ell supernatant ontaining the soluble protein
fration and dissolved inlusion bodies were loaded on a SDS gel.
Cell desintegration was performed from a 1ml shake ask sample or 1mg CDW fed-bath
ultivation sample. To ell pellets 200µl ell desintegration buer (all used reagents are
given in appendix tables 6, 7 and 8) was added and samples were vortexed until the
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pellet was ompletely resuspended. For ell disruption 50µl of 2mg/ml lysozyme and
50µl benzonase were added and inubated for 10min at RT (shaking on a TurboMix).
After addition of 100µl triton X-100 samples were inubated again for 10min at RT
(shaking on a TurboMix). Centrifugation for 10min at 4°C and 13000rpm separates the
ell debris from the dissolved proteins in the supernatant. Supernatant was transferred
into a fresh Eppendorf tube and stored at 4°C until loading on the NuPAGE gel. The
pellet ontains beside ell debris also inlusion bodies and was washed two times with
1ml wash buer (Tris/HCl, pH = 8.2, 100mM). Samples were vortexed until pellet was
resuspended ompletely and entrifuged for 10min at 4°C and 13000rpm. The IB-pellet
was resuspended in 400µl solvent buer and inubated for 30min (shaking at TurboMix).
After 10min entrifugation supernatant ontaining the dissolved inlusion body proteins
ould be used for SDS gel eletrophoresis.
Used SDS gels were NuPAGE 4-12% BisTris gradient gels, as running buer a MES (2-(N-
morpholino) ethanesulfoni aid) buer was used. NuPAGE LDS Sample buer (4x) and
NuPAGE Reduing Agent (10x) were used for sample loading. Moleular weight marker
was Mark12 ready-to-use (22). Eletrophoresis settings were 200V, 400mA and 30min.
Gels were xed in 50% ethanol, 10% aeti aid (100%) for 30min and stained in Coomassie
Brilliant Blue R250 Solution ontaining 25% Ethanol and 12.5% aeti aid (100%) 10 min.
Destaining solution (25% Ethanol and 12.5% aeti aid (100%)) was added for several
hours or overnight, hanging 1-2 times. Destaining reation was stopped by transferring
the gel to water and gels were sanned using Corel Photo-Paint 12 and pitures analysed
by using ImageQuantTL to determine the ratio between dissolved proteins and proteins in
inlusion bodies.
3.10.2 ELISA
To quantify the onentration of produed reombinant protein in the shaking ask exper-
iments or fed-bath ultivations enzyme-linked immuno sorbent assays were performed.
For ell desintegration 200µl ell desintegration buer (all reagents for ell desintegration
are given in appendix tables 9, 10) was added to the ell pellet (1ml ell suspension
respetively 1mg CDW) and pellet was resuspended ompletely. 50µl lysozyme was added
and ells were inubated for 10min at 37°C, shaking at 350rpm. Then 750µl triton X-100
were added and inubated as previously. After 10min entrifugation at 4°C and 13000rpm
the supernatant was transferred into a fresh Eppendorf tube and ould be stored at -
20°C until the ELISA. All ELISA stok solutions and buers are given in detail in 11 and 12.
ELISA plates were oated with rst antibody 2h at RT or overnight at 4°C. Primary SOD
antibody (mAb IAM-SOD M05) or primary GFP antibody (mAb mouse α GFP Sigma art.
nr. G6539) were diluted in oating buer. Plates were washed three times with water with
Columbus Washer (TECAN art.nr. I209 0049).
Samples and standard were diluted following experiened data to reeive a onentration
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of 50ng SOD/ml in the highest dilution row and 20ng GFP/ml. SOD-standard had a
onentration of 2µg/ml and was diluted for use to a onentration of 50ng/ml in dilution
buer. GFP standard was reombinant GFP (BD Biosiene Clonteh art.nr.632373) with
a onentration of 1mg/ml and diluted in dilution buer to a onentration of 20ng/ml.
GFP ELISA plates had to be bloked with dilution buer for 2h at RT to blok unspei
binding sites on the rst antibody. 300µl samples and standards were added to row H of an
dilution plate and were diluted in 1:2 steps from row G to A (140µl dilution buer already
added in all wells).
50µl of the diluted samples were transferred to the oated ELISA plates and inubation for
1h at RT. After washing for three times 50µl seond antibody were added and inubated for
1h. Anti-SOD antibody is binded to alali phosphatase, whih an atalyze a reation with
the staining solution. Seondary GFP antibody is linked to biotin (goat α GFP biotin AB
Aris R1091B) and an therefore reat with a streptavidin-horseradish peroxidase onjugate
in the staining solution. SOD ELISA plates ould be measured after 10-20min after adding
100µl staining solution per well on a multiple hannel photometer (Sunrise Remote/ Touh
Sreen, TECAN) at 405nm and referene wavelength 620nm.
For GFP ELISA samples were inubated with 100µl streptavidin-HRP onjugate for 1h
after three times washing after seondary antibody inubation. Adding of 100µl staining
solution starts staining reation, whih an be stopped after 3-5 min and plates an be
measured in the photometer. Data were analyzed with software Magellan.
3.10.3 Correlation of SDS page and ELISA data
SDS page analysis was performed to determine the formation of inlusion bodies in the
ourse of ultivation. The SDS page gels were sanned and the sanned pitures were
imported into the ImageQuantTL software. This software an ount the pixels of the
protein bands in the sanned gel photograph and realizes therefore a quantiation of the
protein bands. With the export of the ounted values to Mirosoft Exel, the ratio between
the soluble protein fration and the inlusion body fration ould be alulated.
ELISA analysis quantied the protein amounts in mg/g in the soluble protein fration.
With the ombination of the ELISA data and the ratios determined by ImageQuantTL
software of SDS gel quantiation, total protein levels ould be alulated.
Beause SDS gel eletrophoresis was not performed for all sampling times, the reeived
distribution urve was interpolated. The mean values for all sampling times resulted in the
alulation of total protein amounts for all samples.
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4 Results
In order to determine the limits of reombinant protein expression in hromosomal enoding
E. oli systems, gene onstruts ontaining two opies of the produt gene (GFPmut3.1
and hSOD) were generated. The obtained tandem gene onstruts were integrated in
E. oli prodution hosts and were tested in shake ask and bioreator ultivations. Their
performane was ompared to integrated single opy and plasmid based systems, to evaluate
the expression limits of hromosomal integrated hosts.
4.1 Creation of the expression systems
Plasmid based systems and hromosomal expression systems underlying this work are based
on the high ativity of the T7 RNA polymerase. The produt gene (GFPmut3.1 or hSOD)
of plasmids or single opy produt gene hromosomal integrated strains are under ontrol
of the T7 promoter and the T7 terminator. Additionally they ontain a hlorampheniol
resistane gene with it's own promoter and terminator. The linear assette of the single
gene hromosomal integrated strain was starting point for the reation of the tandem gene
linear assette. Based on the available starting plasmids ontaining the linear assette
(CAT:T7pGFP or T7pGFP:CAT) two dierent loning strategies were developed to reate
two dierent variants of the tandem gene assettes.
Variant 1 was designed with a T7 promoter and T7 terminator for both opies of the
produt gene, interrupted by the gene of the hlorampheniol resistane. In the design of
the variant 2, the two opies of the produt genes share a T7 promoter and a T7 terminator
and are only interrupted by a ribosomal binding site (rbs). The hlorampheniol resistane
gene follows after the T7 terminator.
Cloned assettes were integrated in the hromosomes of the prodution strains BL21(DE3)
and HMS174(DE3) to obtain the tandem gene expression systems.
4.1.1 Cloning of linear assette variant 1
The two idential produt genes of linear assette variant 1 are under ontrol of their own
T7 promoter and T7 terminator. The two genes are interrupted by the hlorampheniol
resistane gene, whih has it's own promoter and terminator.
Starting plasmids for the reation of the linear assette variant 1 were
pBKS(−):Tn7::CAT:T7pGFP, ontaining a linear assette enoding the hlorampheniol
resistane gene and a single opy of the produt gene, and pBKS(−):Tn7::T7pGFP:CAT,
ontaining the produt gene and resistane gene in a reversed alignment.
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Figure 7: Starting plasmids: pBKS(−) with linear assettes Tn7::CAT:T7pGFP or
Tn7::T7pGFP:CAT
Figure 7 shows the linear assettes of starting plasmids pBKS(−):Tn7::CAT:T7pGFP and
pBKS(−):Tn7::T7pGFP:CAT, whih were also alled plasmid 1-GFP and plasmid 3-GFP.
For linear assettes ontaining hSOD produt gene, the same starting plasmids were used
ontaining the gene for hSOD instead of GFPmut3.1.
For the loning strategy of the linear assette variant 1, two PCR reations were designed.
Figure 8: Cloning proedure of linear assette variant 1
PCR of plasmid 1 taking primers BglII-CAT-for and Tn7-ho2-bak resulted in a PCR prod-
ut of 2413bp for GFPmut3.1 and 2161bp for hSOD and PCR of plasmid 3 taking primers
Tn7-ho1-for and BglII-T7term-bak delivered a PCR produt of 1220bp for GFPmut3.1
and 968bp for hSOD. After puriation of the PCR produts a BglII digestion was per-
formed and puried restrition fragments were ligated, resulting in the linear assette of the
aurate size. Figure 8 illustrates the single steps of the loning proedure of linear assette
variant 1.
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4.1.2 Cloning of linear assette variant 2
The idential produt genes in linear assette variant 2 were arranged next to eah
other, only separated by a ribosomal binding site (rbs), sharing the T7 promoter and
T7 terminator. The linear assette variant 2 was reated in a similar way as linear
assette 1, but in order to reeive the target genes diretly after eah other, starting
plasmid 3 was taken for the two PCR reations. PCR reation 1 was using primers
Tn7-ho1-for and SpeI-GFP-bak or SpeI-SOD-bak to obtain PCR produts of 1120bp
length for GFPmut3.1 and 868bp for hSOD. PCR reation 2 using SpeI-rbs-GFP-for
or SpeI-rbs-SOD-for and Tn7-ho2-bak resulted in PCR fragments of 2313bp length for
GFPmut3.1 and 2061bp for hSOD. The subsequent SpeI digest was followed by a ligation,
leading to the linear fragment of the desired size. Figure 9 shows the underlying steps of
the loning proedure of linear assette variant-2.
Figure 9: Cloning proedure of linear assette variant 2
4.1.3 Results of the Cloning
The produt yields after the individual PCR reations lead to suient produt for re-
strition digestions. After several trials it appeared to be more useful to lean up the PCR
fragments and the digested PCR fragments only by a PCR lean-up kit and not by agarose
gel eletrophoresis to enhane the onentration of produts. After ligation the long formed
DNA of about 3500bp had to be amplied by PCR to reeive suient amounts of the
linear assettes with the tandem genes. Optimization of the PCR reation was neessary,
beause of enountered missing produt formation after ligation. The rise of the annealing
time and the inrease of PCR yles lead to DNA onentrations high enough to work with.
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To verify the sequene of the ligated onstrut, DNA had to be sequened. The sequening
of the linear assettes was performed with Tn7-ho1-for and Tn7-ho2-bak primers and T7
promoter and T7 terminator primers to ensure the sequene auray. Beause of the
possible emerging mutations during ampliation by KOD-XL polymerase, only sequened
heked PCR produts were used for the genome integration. Figure 10 shows the agarose
gel photograph of the four dierent linear tandem gene assettes generated by PCR (Var
1-GFP has a size of 3633bp, Var 1-SOD a size of 3129bp, Var 2-GFP a size of 3433bp and
Var 2-SOD a size of 2929bp).
Figure 10: PCR produts of the linear assettes var 1-GFP, var 2-GFP, var 1-SOD
and var 2-SOD
Cloning of the right sequened linear tandem gene assettes into pBKS(-) vetors, ould
be suessfully performed for linear assette variant 2-SOD. Mutations ourred in the
other linear assettes (var1-GFP, var2-GFP and var1-SOD) loned into pBKS(-) vetors.
A repetition was not performed, beause of time reasons.
An important step to optimize the prodution of the linear assettes by PCR would be
the optimization of the PCR reation itself. The utilization of dierent PCR polymerases,
as the Pfu polymerase, the taq polymerase, the KOD-HiFi polymerase and the KOD-XL
polymerase, showed greatest suess with the KOD-XL polymerase. The inrease of the
PCR yles from 30 to 35 yles resulted in higher PCR produt yields. The time-onsuming
experiments, whih would be neessary to gain a further optimization stayed unattended
at the expense of the integration of the linear assettes into the host hromosome.
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4.1.4 Chromosomal integration
λ Red reombination
Genome integration was started with transformation of linear assette variant 2-GFP and
SOD into Mg1655 E. oli baterial ells. Mg1655 strain ontains the Red helper plasmid
pKD46, whih is the plasmid with the λ Red genes gam, bet and exo under the ontrol
of ParaB promoter. pKD46 has a tl3 terminator and a temperature-sensitive origin, as
desribed by Datsenko and Wanner [18℄. For genome-integration 200, 400 and 600ng of
linear DNA were used and positive lones reeived after transformation were analyzed by
PCR sreening.
Figure 11 shows the agarose gel of the PCR sreening of Mg1655 lones. Primers
binding at external sites outside of the Tn7 homologies were used to onrm the right
integration of the linear assette, ex1-for and ex2-bak primers giving a PCR produt
of 3633bp. A PCR reation with primer pairs (ho1-for and BsmBI-CAT-for resulting in
a 2790bp fragment) and (ex1-for and BSMBI-CAT-for resulting in a 2890bp fragment)
were used to verify the right length of the insert. Figure 11 shows 2 positive lones
arrying a fragment of orret size. The bands of about 800bp in lane 1 and 4 result
from dead ells on the plate taken for the PCR reation, whih have no linear assette
integrated. The size of 800bp is determined by the length of the homology regions
whih is about 300bp eah and by the length of the external regions whih is about
100bp eah. After re-plating the lones on fresh plates ontaining hlorampheniol, this
negative band disappears. DNA was sequened after the ure of the pKD46 helper plasmid.
Figure 11: Agarose gel of PCR sreening of 2 lones piked after genome integration
of linear assette variant 2- GFP into Mg1655 hromosome
Cure of the pKD46 plasmid is generated by the repeated streak-out on LB plates with
hlorampheniol inubated at 42°C. The temperature-sensitive origin of repliation (ORI)
of the pKD46 plasmid avoided the ampliation of the plasmid under suh high tempera-
tures. Although lones were reeived bearing an integrated linear assette with the aurate
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sequene, the integration strategy in detail desribed in materials and methods 3.6.1 was
not pursued. The time-onsuming steps of phage P1 transdution and reeptor strain
(HMS174(DE3) or BL21(DE3)) infetion ould be avoided by the use of the Quik & Easy
E. oli Gene Deletion Kit (see referene [1℄ and subsetion 3.6.2).
Quik & Easy E. oli Gene Deletion Kit
Chromosomal integration using the Quik & Easy E. oli Gene Deletion Kit failitates the
genome integration proedure by permitting a diret integration of the linear assette into
the prodution host. An intermediate integration into a loning host followed by a P1
phage transdution is not neessary anymore, whih helps to save time and working eort.
The Quik & Easy E. oli Gene Deletion Kit depends mainly on the usage of the pRedET
plasmid, whih has the λ Red genes under the ontrol of ParaB promoter and additionally
the ReA gene. This plasmid allows a diret integration of the linear assette into the host
strain, for example HMS174(DE3), a reA-deient strain.
HMS174(DE3) strain
Optimization of the Quik & Easy E. oli Gene Deletion Kit manual had to be performed
for the use of HMS174(DE3) strain. Figure 12 shows the individual steps of the integration
proedures. The pRedET plasmid arries the red α, β, γ genes of the λ phage together
with the reA gene in a polyistroni operon under the ontrol of the induible ParaB
promoter, whih limits the reombination window therefore by the transient expression of
the Red proteins.
Transformation of pRedET plasmids arrying ampiillin or tetrayline resistane were
performed aording to the Quik & Easy E. oli Gene Deletion Kit (see 3.6.2) in E.
oli strains HMS174(DE3) and BL21(DE3). E. oli strains arrying the pRedET plasmid
were stored at -80°C until genome integration was performed. To test the eieny of
the genome integration method, HMS174(DE3) ells were used. Beause of the time
and work-onsuming proedure to reeive enough amount of DNA for the long tandem
gene PCR assettes to be integrated, a shorter linear assette was hosen to test the method.
Plasmid-1-GFP was used for the optimization of the Quik & Easy E. oli Gene Deletion
Kit for HMS174(DE3) ells. Following the individual steps desribed in subsetion 3.6.2
the integration of 500ng Tn7::CAT:T7pGFP assette in repliates, resulted in 60 and
150 lones on the two plates for pRedET-Amp plasmid and 400 and 500 lones for
pRedET-Tet plasmid. To analyse the orret insertion of the linear assette, a PCR sreen
was performed, whih showed that all lones had the linear assette (Tn7::CAT:T7pGFP)
integrated. Sequening veried the observed results and showed that the Quik & Easy E.
oli Gene Deletion Kit worked well for HMS174(DE3) ells.
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Figure 12: Quik & Easy E. oli Gene Deletion Kit- individual steps
Beause of the positive results from the test integration with linear assette
Tn7::CAT:T7pGFP, HMS74(DE3) strain with pRedET-Tet plasmid was hosen for
the genome integration of the tandem gene assettes. The preferene for the pRedET-Tet
plasmid was given, beause of the high yield of lones after integration, whih was 2-3
times higher as for ampiillin pRedET plasmid in the test integration. Another reason was
the demand of the pharma industry to avoid the usage of ampiillin arrying plasmids in
reombinant protein prodution proesses. Although the pRedET plasmids are eliminated
by the ultivation of the baterial ells at 37°C, ampiillin resistane existed at distint
steps.
Integration of linear assette variant 1-GFP and SOD and variant 2-GFP and SOD was
performed in one experimental approah, using HMS174(DE3) pRedET-Tet strain. To
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obtain an optimal amount of positive lones dierent onentrations of PCR produt were
used. 400 and 600ng DNA resulted in 20-200 lones on all plates. As a negative ontrol in
whih expression of λ red genes was not indued by arabinose, linear assette var2- GFP
was used, beause of the highest onentration of DNA.
PCR sreening of positive lones ould be performed on the day after tansformation. 7
lones from eah variant were analysed by sreening PCR using ex1-for and ex2-bak
primers. Figure 13 shows the agarose gel photograph of the PCR produt of the external
primer pair for one lone of eah linear assette. Clones shown are variant 1- GFP lone
#7 (3833bp with external primers), variant 1- SOD lone #6 (3329bp with external
primers), variant 2- GFP lone #4 (2633bp with external primers) and variant 2- SOD
lone #5 (3129bp with external primers), whih were sequened, to verify the orretness
of the integrated sequene. 800bp negative band an be seen for all lones. Sequening
showed that all four taken lones had a orret inserted tandem gene assette.
Figure 13: Agarose gel of PCR sreen of genome integrated tandem assettes into
host strain HMS174(DE3)
BL21(DE3) strain
The suessful prodution of HMS174(DE3) host ells arrying eah of the four onstruted
assettes lead to the desire to integrate the tandem gene assettes also into the BL21(DE3)
genome. BL21(DE3) genome integration using the Quik & Easy E. oli Gene Deletion
Kit was repeated two times and did not result in any lones at all. The inreased growth
of BL21(DE3) ells after the shift from 30°C to 37°C brings about only a short inubation
time at 37°C, whih is neessary to start transription of λ red genes, or a ell density,
whih brings ells out of the exponential growth phase. Both fats ould be the reason for
the ineient genome integration. A large approah to test dierent ell densities, dierent
inubation times at 37°C or dierent DNA onentrations would be neessary to establish
the genome integration using the Quik & Easy E. oli Gene Deletion Kit in BL21(DE3),
but was not realized in the ourse of this work, beause of time reasons.
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4.2 Testing of the onstruts under ultivation onditions
4.2.1 Creation of ell banks
In order to obtain a reproduible inoulum in the experiments, it is neessary to reate ell
banks, in whih ells were grown under equal onditions and are stored at equal densities.
Overnight ultures of positive HMS174(DE3) lones were frozen in 1.5ml aliquots
and stored as a researh ell bank (RCB). Master ell banks (MCB) were pre-
pared for HMS174(DE3):Tn7::GFP:CAT:GFP, HMS174(DE3):Tn7::SOD:CAT:SOD and
HMS174(DE3):Tn7::SOD:SOD:CAT strains, aording to the desription given in 3.7.2.
A master ell bank of HMS174(DE3):Tn7::GFP:GFP:CAT ould not be prepared, beause
the ells did not grow in the M9-ZB medium used for master ell bank preparation.
4.2.2 Shake ask experiments
Shake ask ultivations were performed to test the funtionality of the reated linear as-
settes, to determine the produt yield of the reombinant protein and to analyse the inu-
ene of the produt formation on the ellular growth. The ultivation medium was hanged
from LB to semisyntheti medium, to provide proess onditions equal to bioreator ulti-
vations. Produt formation of soluble reombinant protein was maintained by ELISA and
inlusion body aggregated protein by SDS page analysis.
The behavior of the tandem gene strain was ompared to a single opy integrated referene
strain. The experiments were performed aording to the desription given in 3.8.
Funtionality test of GFP onstruts
To test the funtionality of the GFP onstruts a shake asks experiment was per-
formed with 40ml LB medium. GFP expression of HMS174(DE3):Tn7::GFP:CAT:GFP
and HMS174(DE3):Tn7::GFP:GFP:CAT strain was started at an OD600 = 1.2. Samples
were taken prior indution, 1h post indution and after 20h post indution.
GFP expression was found for both tandem GFP variants. Figure 14.1 shows the GFP pro-
dution levels measured by oine uoresene 20h post indution and indiates a higher
prodution apaity for linear assette variant 1- GFP. The uoresene values are shown
in dependene on OD600 values. After 20h of prodution the ulture broth was stained
green, beause of GFP prodution, shown in Figure 14.3. The green staining ould also be
determined after entrifugation of the ulture broth in the ell pellet, shown in Figure 14.2.
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Figure 14: GFP amounts after 20h post indution of 40ml shake ask experiment
Shake ask ultivations of GFP onstruts
Shake ask ultivation of HMS174(DE3):Tn7::GFP:CAT:GFP and the referene strain
HMS174(DE3):Tn7::CAT:GFP showed that both strains have the same growth behavior
and produe similar amounts of soluble GFP, deteted by oine uoresene.
In Figure 15 the diagramm 1 shows the ourses of baterial growth given by the OD600
values. The ellular uoresene in relation to the OD600 is also given in the diagram and
shows inreased levels of soluble GFP for the tandem gene strain at 3h post indution,
whih was also onrmed by GFP-ELISA (Fig.15.3). Inlusion body formation was de-
teted for samples 3h post indution. SDS gel presented in Figure 15.2 shows inlusion
body formation for both strains, but a higher amount of inlusion bodies for the tandem
gene strain.
Tandem gene strain has a higher amount of soluble protein, a strong inreased amount
of protein aggregated in inlusion bodies and therefore a higher total protein yield. The
ratio of soluble protein to inlusion body aggregated protein of 73% to 27% in the single
opy strain was shifted to 54% soluble protein to 46% inlusion body aggregated protein
in the tandem gene strain. Total protein amounts in the single opy strain were 38mg/g
reombinant protein and in the tandem gene strain 55mg/g reombinant protein at 3h post
indution.
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Figure 15: Single opy strain HMS174(DE3):Tn7::CAT:GFP and tandem gene strain
HMS174(DE3):Tn7::GFP:CAT:GFP in the ourse of a 400ml shake ask experiment.
Growth behavior of the strains given in 15.1, SDS page analysis in 15.2 and total
protein quantiation in 15.3.
Shake ask ultivations of SOD onstruts
The omparison of tandem gene strains HMS174(DE3):Tn7::SOD:CAT:SOD
and HMS174(DE3):Tn7::SOD:SOD:CAT with the referene strain
HMS174(DE3):Tn7::CAT:SOD in a shake ask ultivation showed that reombinant
protein produtivity is inreased for the tandem gene onstrut variant 1.
The omparison of the growth urves, given in Figure 16.1 by the measured OD600 values,
shows that all three ultivated strains have similar growth rates.
SDS page and ELISA samples were taken 3h post indution. SDS page gel eletrophoresis
showed no inlusion body formation for all three strains (Fig.16.2). The total protein
amount is equivalent to quantied ELISA protein onentrations, beause of the absene
of inlusion bodies. Total protein amounts are presented in Figure 16.3 and show that the
tandem gene strain with the hSOD variant 1 integrated had the highest level of hSOD,
the referene strain and the tandem gene strain with variant 2 produe similar levels of
hSOD.
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Figure 16: Single opy strain HMS174(DE3):Tn7::CAT:SOD and the tandem gene
strains HMS174(DE3):Tn7::SOD:CAT:SOD and HMS174(DE3):Tn7::SOD:SOD:CAT
in the ourse of 400ml a shake ask experiments
Conlusion of shake ask experiments
Shake ask experiments were useful to hek the funtionality of the new tandem gene
integrated HMS174(DE3) strains. The funtionality of the integrated assettes ould be
demonstrated for all four onstruts. It was shown that the linear assette variant 1,
ontaining two independently transribed opies of the target gene, inreases the level of
produed target gene in omparison to the hromosomal integrated strain with one opy of
the target gene. Inlusion body formation in the ourse of GFP onstrut ultivation was
observed.
4.2.3 Bioreator ultivation
Bioreator ultivations were performed to test the prodution strains in stable and dened
ultivation onditions. In the ourse of a bioreator ultivation the produt formation rates
an be alulated, beause of the high amount of dened points of sampling. Tandem gene
strain HMS174(DE3):Tn7::SOD:CAT:SOD was taken for bioreator ultivation, beause of
the deteted high produtivity of fully soluble reombinant protein in shake ask experi-
ments. The Fed-bath ultivation was run with a arbon limited exponential feed and the
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growth rate was set to µ = 0.1 ∗ h−1 (detailed desription given in 3.9).
The behavior of the tandem gene strain under bioreator onditions, was ompared to a sin-
gle opy hromosomal system and a plasmid based system. HMS174(DE3):Tn7:CAT:SOD
and HMS174(DE3) pet30s(hSOD) are the strains of the referene ultivations.
Cultivation behavior of the tandem gene strain
The omparison of the tandem gene strain ultivation with the referene ultivations of
the single opy strain and the plasmid strain show that the tandem gene strain shows an
intermediate behavior between the two other systems.
The plasmid based system is haraterized by a high produt formation rate of 35-40mg/gh
starting immediately post indution, shown in Figure 17.1. This high reombinant protein
formation, whih is turned on by the indution of the strong T7 expression system, exeeds
the ellular prodution apaity. The inuene of the produt formation on the growth
rate is enormous, whih an be derived from the deviation of the atual CDW from the
alulated CDW. FACS analysis of the ells showed that ells stop to grow, but do not dye
after indution.
Cell growth stops 2h post indution, but produt formation is maintained for more than
8h. This means that produt formation is deoupled from ellular growth. The resulting
inrease in reombinant protein amount depends therefore not on the inrease of biomass,
but on the metabolization of host ell proteins.
The spei ontent of reombinant protein reahes a maximal level of 200mg/g CDW,
but reombinant protein prodution is stopped 9h post indution, beause of the metaboli
overload on the host ells..
In the experiment with the single opy strain (Fig.17.2) growth and produt formation
were maintained over the whole proess. For the rst 15h a onstant qP of about 25mg/gh
was alulated. In omparison to the stop of growth aused by the reombinant protein
prodution from plasmids, the indution of reombinant protein expression in the hro-
mosomal system has a relatively mild inuene on the growth rate of the host ell. The
spei reombinant protein prodution reahes a value of 180mg/g CDW at the end of
the proess and is growth-oupled until the end of the proess. With this system host ell
apaity is not exeeded, whih allows onstant prodution.
Reombinant protein prodution in tandem gene integrated hosts (Fig.17.3) showed, that
two idential opies of the produt gene, lead to a higher qP, but a dereased growth rate.
The qP reahed in this proess was about 25-30mg/gh. The derease of the qP after 8h
post indution orrelates with the inreasing aberration of the atual CDW from the alu-
lated CDW. The growth delines to half of the alulated growth rate, but prolongs until
the end of the proess. Spei reombinant protein prodution is higher for the tandem
gene strain than for the single opy strain and reahes a maximal level of 240mg/g CDW.
With the additional produt gene opy, the limits of the host ell prodution apaities are
reahed. The additional protein synthesis inuenes the host ell growth rate, but does not
ause a omplete stop of growth as deteted in plasmid systems.
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Figure 17: Bioreator ultivations of plasmid strain HMS174(DE3)pet30a(hSOD),
single opy strain HMS174(DE3):Tn7::CAT:SOD and tandem gene strain
HMS174(DE3):Tn7::SOD:CAT:SOD
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Spei reombinant protein prodution
The quantiation of reombinant protein levels of the plasmid based system showed that
the host ell produes about 200mg/g CDW reombinant protein at the end of the proess,
but about 60% of the produed reombinant protein is stored in inlusion bodies. Figure
18.1 shows total protein amounts in the ourse of ultivation and the distribution of the
reombinant protein in soluble protein and inlusion body aggregated protein. In the rst
2h post indution produed reombinant protein stays soluble and reahes a value of 60mg
reombinant protein per g CDW. This soluble reombinant protein ontent remains the
same throughout the proess and starting with 2h post indution produed reombinant
protein aggregates in inlusion bodies. Subsequent reombinant protein prodution only
inreases the levels of protein in inlusion bodies, but not in the soluble fration. The
ratios of inlusion body to soluble protein throughout the ultivation proess are presented
in the diagram 1 in Figure 20.
The single opy hromosomal integrated strain produes at the end of the proess 180mg
hSOD/g CDW, whih stay soluble and do not aggregate in inlusion bodies. Figure 18.2
shows the spei reombinant protein amounts in the ourse of the ultivation. The total
protein amounts are given by the soluble protein amounts, beause no inlusion bodies
were formed in the proess.
What an be onluded from this ultivation is, that the produt onentration of the
reombinant protein is presumably not responsible for the formation of inlusion bodies,
beause the spei reombinant protein amounts are similar for the plasmid based and
single opy system. The high produt formation rate in the plasmid based systems seems
to overload the host ell protein folding mehanisms and auses therefore the inlusion
body formation. The single opy hromosomal system does not ause suh an overload on
the protein folding mehanisms of the host ell.
The reombinant protein levels in the tandem gene strain are higher than in the single
opy strain, but inlusion bodies are formed in the ourse of ultivation. As Figure
18.3 shows, inlusion body formation starts very early in the proess, almost 3h post
indution. This phenomenon was observed by SDS page gel eletrophoresis as shown in
Figures 19.2 and 19.3. Sine from the gel in Figure 19.2 IB formation between 3 to 7h
post indution an be derived, a more detailed analysis was performed to determine the
starting point of IB formation. Figure 19.3 shows that IB formation starts already 4h af-
ter indution. In ontrast the single opy onstrut does not show IB formation (Fig. 19.1).
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Figure 18: Total protein amounts of plasmid strain HMS174(DE3)pet30a(hSOD),
single opy strain HMS174(DE3):Tn7::CAT:SOD and tandem gene strain
HMS174(DE3):Tn7::SOD:CAT:SOD
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Figure 19: Detetion of inlusion body formation by SDS page gel eletrophore-
sis of single opy strain HMS174(DE3):Tn7::CAT:SOD and tandem gene strain
HMS174(DE3):Tn7::SOD:CAT:SOD in the ourse of a bioreator ultivation (Sample
number is equivalent to feed duration)
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Figure 20: Ratios of inlusion body formation and soluble protein of
plasmid based system HMS174(DE3)pet30a(hSOD) and tandem gene system
HMS174(DE3):Tn7::SOD:CAT:SOD
The ratio of inlusion body to soluble protein over the ourse of ultivation for the tandem
gene onstrut is given in Figure 20.2. The diagram shows the inrease of inlusion body
formation throughout the proess with a maximum of 35% inlusion bodies. In omparison
the plasmid based system (Fig.20.1) produes up to 60 % IBs.
The tandem gene integrated strain produes with a higher qP at the beginning of the
proess and attains a higher ontent of spei reombinant protein. The level of the
soluble fration is similar to the single opy onstrut, whereby the additional amount
of reombinant protein aumulates as IBs. It seems that the maximum onentration
of soluble hSOD is reahed by the single opy strain and lies about 180mg reombinant
protein per g CDW.
However, the integration of a seond produt gene in the host hromosome did not lead to
the omplete overload of the host metabolism, as it is seen with plasmid based systems. In
order to avoid inlusion body formation, a tuning regime should be applied to ontrol the
transription rate in relation to metaboli apaity of the host ell.
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5 Conlusion
The aim of the work was the reation of a tandem gene hromosomal integrated expression
system in order to determine the produtivity limits of the hromosomal reombinant E.
oli protein prodution systems.
The linear assettes ontaining idential opies of the produt gene and the subsequent
integration of the assettes into the hromosome of an E. oli prodution host was
suessfully performed. Tandem gene integrated hosts repliate stable and the system
showed high stability during ultivations.
The reombinant protein prodution ould be eiently indued and ultivation experi-
ments in shake ask or bioreator showed superior produt formation rates then the single
opy strains. However tandem gene systems redued growth, whih an be referred to
inreased reombinant protein prodution. Nonetheless the overall yield of tandem gene
systems is lower than single opy strains.
While essation of growth, whih is a problem of plasmid based systems, ould not be
observed in the tandem gene system, inlusion body formation was deteted in plasmid
and tandem gene systems, as well. The aggregation an presumably be addressed to
the overload of the host ell folding mahinery due to the higher qP resulting from the
additional opy in the tandem gene strain.
Although the expression of the reombinant protein exeeded the apaity of the tandem
gene strain, the determination of the aurate limits of the prodution apaity is diult.
The reasons therefore are the maintainane of reombinant protein prodution over a
longer period of time in omparison to plasmid based systems. An important observation
was that the hromosomal system did not ollapse, as it is the ase for plasmid based
systems.
Considering the results of the presented experiments it omes lear that the expression of
reombinant protein by tandem gene assettes in ombination with tuning strategies for
ontrolling the transription rate shows high potential for the development of an eient
prodution system. Moreover it an be strongly assumed that translation rather than
transription poses the bottlenek of reombinant gene expression.
REFERENCES 52
Referenes
[1℄ http://www.genebridges.om/gb/pdf/k006-eoli-gene-deletion-kit-v2.0-2007.pdf.
[2℄ http://www.lg.o.uk/pdf/barode20yer-web202008.pdf.
[3℄ http://www.mirobiology.emory.edu/altman/f-protools/f-tetramers/autoind-
annot.html.
[4℄ http://www.mun.a/biohem/ourses/3107/topis/ara-operon.html.
[5℄ http://www.nanodrop.om/tehsupport/nd-1000-users-manual.pdf.
[6℄ http://www.neb.om/nebeomm/teh-referene/restrition-enzymes/overview.asp.
[7℄ http://www.neb.om/nebeomm/tehbulletinles/tehbulletinm0202.pdf.
[8℄ http://www.promega.om/tbs/tb225/tb225.pdf.
[9℄ http://www.promega.om/tbs/tb308/tb308.pdf.
[10℄ B. Alberts, A. Johnson, J. Lewis, M. Ra, K. Roberts, and P. Walter. Moleular
Biology of the Cell. Garland Siene, a member of the Taylor&Franis group, 2002.
[11℄ P. O. Angrand, N. Daigle, F. van der Hoeven, H. R. Shöler, and A. F. Stewart.
Simplied generation of targeting onstruts using ET reombination. Nulei Aids
Researh, 27, 1999.
[12℄ G. Antranikian. Angewandte Mikrobiologie. Springer Verlag, 2006.
[13℄ B.J. Bahmann. Pedigrees of some mutant strains of Esherihia oli K-12. Bateri-
ology Reviews, 36:525557, 1972.
[14℄ F. Baneyx. Reombinant protein expression in Esherihia oli. Current Opinion in
Biotehnology, 10:411421, 1999.
[15℄ M. Bzymek and S. T. Lovett. Instability of repetitive DNA sequenes: The role of
repliation in multiple mehanisms. PNAS, 98:83198325, 2001.
[16℄ M.M. Carrio and M. Villaverde. Protein aggregation as baterial inlusion bodies is
reversible. FEBS letters, 489:2933, 2001.
[17℄ M. Cserjan-Pushmann, W. Kramer, E. Duerrshmid, G. Striedner, and K. Bayer.
Metaboli approahes for the optimisation of reombinant fermentation proess. Ap-
plied Mirobiology and Biotehnology, 53:4350, 1999.
[18℄ K. A. Datsenko and B. L. Wanner. One-step inativation of hromosomal genes in
Esherihia oli K-12 using PCR produts. PNAS, 97:66406645, 2000.
REFERENCES 53
[19℄ J.D. Diaz-Rii and M.E. Hernandez. Plasmid-eets on Esherihia oli metabolism.
Critial Reviews in Biotehnology, 20:79108, 2000.
[20℄ P.M. Doran. Bioproess Engineering Priniples. Aademi Press, San Diego, 2003.
[21℄ P. Feng, S. Weagant, and M. Grant. Enumeration of Esherihia oli and the oliform
baeria. Bateriologial Analytial Manual, 8, 2002.
[22℄ N. J. Gay, V. L. J. Tybulewiz, and J. E. Walker. Insertion of transposon Tn7 into
Esherihia oli glmS transriptional terminator. Biohemial Journal, 234:111117,
1986.
[23℄ R. Grabherr, E. Nilsson, G. Striedner, and K. Bayer. Stabilizing plasmid opy num-
ber to improve reombinant protein prodution. Biotehnology and Bioengineering,
77:142147, 2002.
[24℄ C. H. Gray and E.L. Tatum. X-ray indued growth fator requirements in bateria.
Pro. Nat. Aad. Si. USA, 30:404410, 1944.
[25℄ L. M. Guzman, D. Belin, M. J. Carson, and J. Bekwith. Tight regulation, modulation,
and high-level expression by vetors ontaining the arabinose pBAD promoter. Journal
of Bateriology, 177:41214130, 1995.
[26℄ J. Lederberg and J.L. Tatum. Gene reombination in Esherihia oli. Nature, 158:558,
1946.
[27℄ A. S. Morag, C. J. Saveson, and S. T. Lovett. Expansion of DNA repeats in Esherihia
oli: eets of reombination and repliation funtions. Journal of Moleular Biology,
289:2127, 1999.
[28℄ K. C. Murphy and K. G. Campellone. Lambda Red-mediated reombinogeni engi-
neering of enterohemorrhagi and enteropathogeni Esherihia oli. BMC Moleular
Biology, 2003.
[29℄ K.C. Murphy. Use of bateriophage λ reombination funtions to promote gene re-
plaement in Esherihia oli. Journal of Bateriology, 180:20632071, 1998.
[30℄ J. P. P. Muyrers, J. Zhang, G. Testa, and F. A. Stewart. ReE/ReT and Redα/Redβ
initiate double-stranded break repair by speially interating with their respetive
partners. Genes Development, pages 19711982, 2000.
[31℄ A. R. Poteete. What makes the bateriophage λ Red system useful for geneti en-
gineering: moleular mehanism and biologial funtion. FEMS Mirobiology letters,
201, 2001.
[32℄ H. Reisher, I. Shotola, G. Striedner, F. Pötshaher, and K. Bayer. Evaluation of the
GFP signal and its amplitude for novel on-line monitoring strategies of reombinant
fermentation proess. Journal of Biotehnology, 108:115125, 2004.
REFERENCES 54
[33℄ C. J. Saveson and S. T. Lovett. Enhaned deletion formation by aberrant DNA repli-
ation in Esherihia oli. Genetis, 146:457470, 1997.
[34℄ H.P. Sorensen and K.K. Mortensen. Advaned geneti strategies for reombinant pro-
tein expression in Esherihia oli. Journal of Biotehnology, 115:113128, 2005.
[35℄ G. Striedner, M. Cserjan-Pushmann, F. Pötshaher, and K. Bayer. Tuning the
transription rate of reombinant protein in strong Esherihia oli expression systems
through repressor titration. Biotehnology Progress, 19:14271432, 2003.
[36℄ G. Striedner, I. Pfaenzeller, M. Luhner, S. Nemeek, R. Grabherr, and K. Bayer.
Plasmid-free T7 based Esherihia oli expression system. in preparation, 2008.
[37℄ F.W. Studier, A.H. Rosenberg, J.J. Dunn, and J.W. Dubendor. Use of T7 RNA
polymerase to diret expression of loned genes. Methods Enzymology, 185:6089,
1990.
[38℄ J. R. Swartz. Advanes in Esherihia oli prodution of therapeuti proteins. Current
Opinion in Biotehnology, 12:194201, 2001.
[39℄ Y. Zhang, F. Buhholz, J.P.P. Muyrers, and A.F. Stewart. A new logi for DNA
engineering using reombination in Esherihia oli. Nature Genetis, 20:123128,
1998.
6 ABBREVIATIONS 55
6 Abbreviations
AA amino aid
amp ampiillin
bp base pairs
fu olony forming units
am hlorampheniol
CAT hlorampeniol trasnferase
DMSO Dimethyl-Sulfoxide
DNA desoxyribonulei aid
E. oli Esherihia oli
ELISA Enzyme-Linked Immunosorbent Assay
GFP green uoresent protein
h hour(s)
HPLC High Performane Liquid Chromatography
IPTG isopropyl β-D-thiogalatopyranoside
kD kilo Dalton
MCB master ell bank
min minute(s)
mRNA messenger ribonulei aid
OD600 optial debsity at wavelength of 600nm
PBS phosphor buered saline
PCR polymerase hain reation
qP spei produt formation rate
RCB researh ell bank
rfu relative uoresene unit [arbitrary unit℄
hSOD human superoxid (Cu/Zn) dismutase
RNA ribonulei aid
rpm rotations per minute
se seond(s)
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7 Appendix
7.1 Cultivation of E. oli- media and buers
All hemials were purhased from Merk unless otherwise noted.
7.1.1 Stok solutions
Ampiillin stok solution
100mg/ml ampiillin dissolved in RO-H2O, sterile ltered; working onentration 100µg/ml
(1:1000)
Chlorampheniol stok solution
25mg/ml dissolved in 96% ethanol, sterile ltered; working onentration 25µg/ml (1:1000)
1M MgSO4
24.6g MgSO4 ∗ 7H2O dissolved in 100ml RO-H2O, autolaved
0,9% sodium hloride solution
9g NaCl dissolved in 1l RO-H2O, autolaved
87% Glyerol
autolaved
Stok solution of trae elements
The hemials given in table 2 were dissolved in 5M HCl. The volume was adjusted to 1l.
The solution was stored in a glass bottle at room temperature.
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Order Component Amount per litre
1 FeSO4 ∗H2O 40.0g
2 MnSO4 ∗H2O 10.0g
3 AlCl3 ∗ 6H2O 10.0g
4 CoCl2 4.0g
5 ZnSO4 ∗ 7H2O 2.0g
6 Na2MoO2 ∗ 2H2O 2.0g
7 CuCl2 ∗ 2H2O 1.0g
8 H3BO3 0.5g
Table 2: Composition of a stok solution of trae elements
7.1.2 Solid media
Luria Bertani (LB) agar
1% NaCl
1% bato-tryptone
0.5% yeast extrat
1.5% agar-agar
The hemials were resuspended in RO-H2O and autolaved. Before the antibioti stok
solution was added the LB agar was adjusted to 56°C. Petri dishes were ast in the laminar
hood and stored at 4°C.
Nutrient agar (NA)
The nutrient agar was used for the determination of olony forming units.
10.0g nutrient broth
7g agar-agar
The hemials were resuspended in 500ml RO-H2O and autolaved. Before the antibioti
stok solution was added the nutrient agar was adjusted to 56°C.
7.1.3 Liquid media
Luria Bertrani (LB) medium
1% NaCl
1% bato-tryptone
0.5% yeast extrat
The omponents were dissolved in RO-H2O and autolaved. Before an antibioti stok
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solution was added the medium had to be ooled. It was stored at 4°C.
M9-ZB medium
The omponents 1 to 4 were dissolved and autolaved separately. After ooling down the
solutions were ombine. The medium was stored at 4°C.
Order Component Amount per litre
1 bato-tryptone 10.0g
1 yeast-extrat 5.0g
1 NaCl 5.0g
1 NH4Cl 1.0g
2 KH2PO4 3.0g
2 Na2HPO4 6.0g
3 Gluose*H2O 4.0g
4 MgSO4 (1M) 1ml
Table 3: Components of M9-ZB medium
Semisyntheti medium for shake ask experiments
The omponents were dissolved separately aording to the order given in table 4. The
gluose solution was autolaved separately and after ooling down added to the medium.
The medium ontains a phosphate buer system. The phosphate salts (omponents 1) were
added per litre of medium. The other omponents (2 to 9) were alulated aording to
the amount of biomass to be produed. For the orret folding of rhSOD, CuCl2 ∗ 2H2O
and ZnSO4 ∗ 7H2O was added to the medium.
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Order Component Amount per litre
1 KH2PO4 3.0g
1 K2HPO4 ∗ 3H2O 4.48g
2 bato-tryptone 0.30g
2 yeast extrat 0.15g
3 Na3 − citrate ∗ 2H2O (ACROS organis) 0.75g
3 MgSO4 ∗ 7H2O 0.30g
4 CaCl2 ∗H2O 0.03g
5 Trae element stok solution 150µl
6 CuCl2 ∗ 2H2O 12mg
7 ZnSO4 ∗ 7H2O 9.6mg
8 (NH4)2SO4 1.35g
8 NH4Cl 1.11g
9 Gluose*H2O 9.90g
Table 4: Components of semisyntheti medium for the prodution of 3g CDW/l
Semisyntheti and syntheti medium for fed-bath ultivations
The semisyntheti medium was used for bath ultivation in bioreators; the syntheti
medium was added during the fed-bath phase. The omponents were dissolved separately
aording to the order given in table 5. The gluose solution was autolaved separately and
after ooling down added to the medium aseptially. The medium ontains a phosphate
buer system. The phosphate salts (omponents 1) were added per litre of medium. The
other omponents were (2 to 9) were alulated aording to the amount of biomass to be
produed. For the orret folding of rhSOD, the medium ontained CuCl2 ∗ 2H2O and
ZnSO4 ∗ 7H2O.
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Order Component
Semisyntheti
(bath) medium
Syntheti (feed)
medium
1 KH2PO4 3.0g 3.0g
1 K2HPO4 ∗ 3H2O 6.00g 6.00g
2 yeast extrat
0.15g -
3 Na3 − citrate ∗ 2H2O (ACROS organis) 0.25g 0.25g
3 MgSO4 ∗ 7H2O 0.10g 0.10g
4 CaCl2 ∗H2O 0.02g 0.02g
5 CuCl2 ∗ 2H2O 4.0g 4.0g
6 ZnSO4 ∗ 7H2O 3.20g 3.20g
7 Trae element stok solution
50µl 50µl
8 Antifoam solution
0.5ml/kg 0.5ml/kg
9 Gluose*H2O 3.00g 3.00g
Table 5: Components of semisyntheti medium (bath) and syntheti medium (feed) for fed-bath
ultivations
7.2 Oine analysis
7.2.1 Protein quantiation
Cell desintegration for NuPage geleletrophoresis
Solutions Conentration Notes
Preparation
Tris/HCl (pH 8.2) 30mM adjusted with 2N HCl
1.817g/500ml; 30ml 100mM
Tris/HCl + 70ml H2O
EDTA 0,5M with KOH
25ml
MgCl2 ∗ 6H2O 200mM -
stok solution: 1M-
(508,3mg/100ml)
Triton X-100 6% in Tris/HCl (pH 8.2)
3g Triton + 47g Tris/HCl
β- meraptoethanol 14.3M - -
Lysozyme 10mg/ml aliquoted at 300µl
4mg/ml: 300µl + 450µl H2O
for IB-desintegration
Benzonase 50 units/ml in benzonase buer
-
Table 6: Stok solutions for ell desintegration
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Contents Volume
Tris/HCl (pH 8.2) 2.7ml
EDTA 150µl
MgCl2 ∗ 6H2O 150µl
β- meraptoethanol 6µl
Table 7: Cell desintegration buer
Solutions Conentration Notes
Preparation
Tris/HCl (pH 8.2) 100mM adjusted with 2N HCl
1.2144g/100ml
urea 8M -
48.05g + 63.98g Tris/HCl
β- meraptoethanol 100mM added freshly 7µl/ml IB-solution buer
Table 8: IB solution buer
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Cell desintegration for ELISA
Solutions
Preparation
Tris-buer
20mMTris-HCl, pH 8.2 (adjusted with 2N HCl);
1.2114g Tris/500ml
EDTA
0.5M EDTA (with KOH) pH 8.2
β- meraptoethanol 14,3M
Lysozyme
10mg/ml
Triton X-100
0.5% Triton X-100 in Tris-buer
Table 9: Stok solutions for ell desintegration of ELISA samples
Solution Volume nal onentration
Tris-buer 4.5ml 18mM
EDTA solution 250µl 5mM
β- meraptoethanol 12.5µl 7mM
Table 10: Desintegration buer for ELISA
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GFP- ELISA- stok solutions and buers
Solutions
Preparation
20mM Tris-HCl, pH = 8.2
242.28mg Tris base in 80 ml RO-H2O adjusted to pH 8.2
with 2N HCl and lled up to 100ml.
0.5M EDTA, pH = 8.0
7.44g EDTA in 80ml RO-H2O adjusted to pH 8.0 with
5M NaOH and lled up to 100ml.
10 mg/ml lysozyme in RO-H2O
0,5% Triton X-100 in 20mM Tris-HCl, pH = 8.2
Resuspension buer
9ml of 20mM Tris-HCl (pH = 8.2), 500µl 0,5M EDTA
(pH = 8.2) and 25µl meraptoethanol freshly prepare
eah day
10 mg/ml OPD stok solution stored at -20°C
Coating buer (0,1N NaHCO3-buer, pH = 9, 6− 9, 8)
8.4g NaHCO3 and 4.2g Na2CO3 in 1l RO-H2O. Buer
an be stored at 20°C up to one week.
Washing buer (PBS, pH = 7, 2− 7, 4)
1.15g Na2HPO4 ∗ 2H2O, 0,2g KH2PO4, 0.2g KCl and
8.0g NaCl in 1l RO-H2O, 1ml Tween 20 is added au-
tiously to avoid foaming. The buer may be stored at
4°C for 3 days.
Dilution buer
1% bovine serum albumin in PBS, an be stored at 20°C
for one day
Staining solution (Na2HPO4/ itri aid; pH = 5.0)
7.3g itri aid*H2O and 11.86g Na2HPO4 in 1l RO-
H2O. The buer an be stored at 4°C up to 4 weeks. A
fresh solution of 10ml buer ombined with 100µl OPD
stok solution and 3µl H2O2 is prepared for eah analysis
Capture antibody (monolonal mouse antibody anti GFP,
Sigma)
diluted 1:1000 in oating buer
Biotinylated seondary antibody (goat anti GFP- biotin,
DPC-Biermann)
diluted 1:2000 in dilution buer
reombinant GFP standard (1mg/ml) diluted to 20ng/ml in dilution buer
Avidin-HRP onjugate (Amersham Pharmaia) diluted 1:1600 in dilution buer
1.25 M H2SO4 35ml 95-97% H2SO4 made up to 1l with RO-H2O
Table 11: Stok solutions and buers for GFP- ELISA
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hSOD- ELISA- stok solutions and buers
Solutions
Preparation
20mM Tris-HCl, pH = 8.2
242.28mg Tris base in 80 ml RO-H2O adjusted to pH 8.2
with 2N HCl and lled up to 100ml.
0.5M EDTA, pH = 8.0
7.44g EDTA in 80ml RO-H2O adjusted to pH 8.0 with
5M NaOH and lled up to 100ml.
10 mg/ml lysozyme in RO-H2O
0.5% Triton X-100 in 20mM Tris-HCl, pH = 8.2
Resuspension buer
9ml of 20mM Tris-HCl (pH = 8.2), 500µl 0.5M EDTA
(pH = 8.2) and 25µl meraptoethanol freshly prepare
eah day
10mg/ml OPD stok solution stored at -20°C
Coating buer (0,1N NaHCO3-buer, pH = 9.6− 9.8)
8.4g NaHCO3 and 4.2g Na2CO3 in 1l RO-H2O. Buer
an be stored at 20°C up to one week.
Washing buer (PBS, pH = 7.2− 7.4)
1.15g Na2HPO4 ∗ 2H2O, 0.2g KH2PO4, 0.2g KCl and
8.0g NaCl in 1l RO-H2O, 1ml Tween 20 is added au-
tiously to avoid foaming. The buer may be stored at
4°C for 3 days.
Dilution buer
1% bovine serum albumin in PBS, an be stored at 20°C
for one day
PNPP (p-Nitrophylphosphat)(100mg/ml) stok solution stored at -20°C
Staining solution ()oating buer + PPNPP solution
A fresh solution of 10ml oating buer ombined with
100µl PNPP stok solution is prepared for eah analysis.
Capture antibody (monolonal mouse antibody IAM-
SOD M05
diluted 1:300 in oating buer
Seond antibody enzyme-marked with alaline phos-
phatase (Mouse mAb IAM-SOD 11H4x4AK)
diluted 1:1000 in dilution buer
reombinant hSOD standard (2µg/ml) diluted to 50ng/ml in dilution buer
Table 12: Stok solutions and buers for SOD- ELISA
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7.3 Cloning methods- media and buers
7.3.1 SOC medium
2% bato-tryptone
0.5% yeast extrat
10mM NaCl
3mM KCl
20mM MgCl2 ∗ 6H2O
20mM Gluose*H2O
10mM MgSO4 ∗ 7H2O
The pH is adjusted to 7.0 with 5N NaOH.
Preparation: 20g tryptone, 5g yeast extrat and 0.58g NaCl were dissolved in 450ml RO-
H2O. After addition of 0.22g KCl the mixture was stirred until the salt was dissolved.
2.03g MgCl2 ∗ 6H2O were added and the volume was made up to 975ml. Then the pH
was adjusted to 7.0 with 5N NaOH. Finally the medium was autolaved. An autolaved
1M gluose stok solution (19,82g gluose*H2O in 100ml water) and a sterile 2M MgSO4
solution (49.3g MgSO4 ∗ 7H2O in 100ml water) were prepared, equilibrated to room tem-
perature and pipetted into the nutrient medium, whereby 20ml gluose and 5ml MgSO4-
solution were added.
7.3.2 Buers and stok solutions
50x TAE buer
242g Tris base
57.1ml glaial aeti aid
100ml of 0.5M EDTA (pH 8.0)
Ethidium Bromide: Stok solution
10mg/ml, stored at 4°C in the dark
3M Na-aetate (pH 5.2)
40g Na-aetate*H2O
The pH is adjusted to 5.2 with glaial aeti aid
0.5M EDTA (pH 8.0)
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7.44g EDTA are dissolved in 80ml ROH2O.
The pH is adjusted to 8.0 with 5M NaOH and lled up to 100ml.
HEPES buer
1M stok solution: 23.83g HEPES in 100ml RO-H2O
1mM HEPES buer: 1:1000 dilution of the stok solution
7.3.3 Primer list
Name
Sequene
BglII-CAT-for
5'- GGA AGA TCT ACG GGG AGA GCC TGA GC- 3'
BglII-T7term-bak
5'- GGA AGA TCT CTC GAG CAA AAA ACC CCT C- 3'
BsmBI-CAT-bak
5'- AAT GAT GCG TCT CAC GAT GCC ATT GGG ATA TAT C-3'
BsmBI-CAT-for
5'- AAT GAT GCG TCT CCA TCG TAA AGA ACA TTT TGA GG- 3'
EoRI-T7term-bak
5'- AGT AGT GAA TTC CAA AAA ACC CCT CAA GAC C- 3'
GFP-SpeI-bak
5'- GGA CTA GTC TTA TTT GTA TAG TTC ATC CAT GCC- 3'
KpnI-attTN7-bak
5'- GTC GTC GGT ACC CAG AGG ACC CTC CTA AG -3'
KpnI-attTN7-for
5'- GTC GTC GGT ACC GTC TCC TGG GAG GAT TC -3'
SalI-CAT-for
5'- ACG CGT CGA CAC GGG GAG AGC CTG AGC -3'
SalI-T7term-bak
5'- ACG CGT CGA CCT CGA GCA AAA AAC CCC TC -3'
SaI-TN7ho1-for
5'- GTC GTC GAG CTC GTT GCG ACG GTG GTA CG -3'
SpeI-rbs-GFP-for
5'- GGA CTA GTA ATA ATT TTG TTT AAC TTT AAG AAG GAG
ATA TAC ATA TGG CTA GCA AAG GAG AAG- 3'
SpeI-rbs-SOD-for
5'- GGA CTA GTA ATA ATT TTG TTT AAC TTT AAG AAG GAG
ATA TAC ATA TGG CGA CGA AGG CCG TGT G- 3'
SOD-SpeI-bak
5'- GGA CTA GTT TAC TAT TGG GCG ATC CC- 3'
Tn7-ho1-for
5'- GTT GCG ACG GTG GTA CG- 3'
Tn7-ho2-bak
5'- GGT ACC TGA AGA AGT TCG C- 3'
Tn7-ex1-for
5'- ACC GGC GCA GGG AAG G -3'
Tn7-ex2-bak
5'- TGG CGC TAA TTG ATG CCG -3'
XhoI-TN7ho2-bak
5'- GAC GAC CTC GAG GGT ACC TGA AGA AGT TCG C-3'
Table 13: Used primers
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7.3.4 PCR set-ups
Contents Volume (µl)
10x KOD-XL buer 5
dNTPs 8
H2O 33.7
primer 1(10pM) 1
primer 2(10pM) 1
DNA (2-20ng) 1
KOD-XL polymerase 0.3
reation volume 50
Table 14: KOD-XL PCR Set-up
Temperature Time Cyles
94°C 1min 1x
94°C 30se 30x
55°C 5se 30x
72°C 3min15se 30x
72°C 10min 1x
Table 15: KOD-XL PCR program
Contents Volume (µl)
10x Thermopolymerase buer 1,5
dNTPs 0.5
DMSO 0.5
H2O 8.9
primer 1(10pM) 1
primer 2(10pM) 1
DNA (2-20ng) 0.5
KOD-XL polymerase 0.1
reation volume 15
Table 16: Taq PCR Set-up
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Temperature Time Cyles
94°C 2min 1x
94°C 15se 30x
55°C 15se 30x
72°C 3min15se 30x
72°C 5min 1x
Table 17: Taq PCR program
7.3.5 Moleular weight markers
Figure 21: O' GeneRulerTM 1 kb DNA Ladder, ready-to-use
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Figure 22: Mark 12
TM
unstained standard
Abstrat
Cultivation of miroorganisms for the prodution of reombinant proteins is of entral im-
portane for many industrial elds. Many pharmaeutial appliations are based nowadays
on reombinant protein prodution. Easy and ost-eient proesses are in high demand,
oering a great researh area for proess optimization and new proess development.
E. oli prodution systems bearing a plasmid enoded heterologuous gene under a strong T7
expression promoter are widely distributed among industrial proesses. Several phenom-
ena enountered by T7 based plasmid systems, suh as plasmid-loss during ultivation or
break down of the system by metaboli overload, are unwelome but aepted side-eets.
Alternative expression systems are only sparsely available, giving plasmid based systems a
predominant role in reombinant protein expression.
New onepts based on the integration of the target gene into the host hromosome oer
features, whih diminish system instabilities enountered by plasmid systems. Stable pro-
esses and high prodution yields plead for the establishment of hromosomal systems in
industrial appliations. Beause of few researh data and lak of experiene with the pro-
dution apaities of suh hromosomal based systems, investigations on produt formation
abilities and limitations of hosts bearing hromosomal-integrated reombinant genes are of
distint importane.
Sine reombinant gene expression by a single opy did not fully overstrain the host ell
metabolism, two idential opies of the gene of interest should be inserted in this work.
Comparisons of ultivation experiments between single and tandem integrated hosts, were
performed to investigate the prodution apaity and limits of this system.
In addition the availability of genome integrated systems provides the prerequisites to
investigate the metaboli load due to plasmid repliation and plasmid enoded protein
expression.
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Kurzfassung
Rekombinante Protein Produktion ist ein zentrales Element der modernen Biotehnologie
und ndet Anwendung in den vershiedensten industriellen Sparten. Viele neue therapeutis-
he Zulassungen in der Pharmaindustrie werden mittels rekombinanter Proteinproduktion
hergestellt. Niedrige Produktionskosten und stabile Prozesse werden von Seiten der In-
dustrie gewünsht, was die Forshung und Entwiklung im Bereih der Prozessoptimierung
vorantreibt.
Plasmid odierte Expression von rekombinanten Genen unter starken Promotoren, wie dem
T7 Promoter System, zählen zu den am häugsten verwendeten Produktionssystemen in E.
oli. Plasmidverlust oder Zusammenbruh des Produktionssystems durh Überbelastung
des Wirtsmetabolismus sind nahteilige, aber akzeptierte Phänomene die durh das Fehlen
von Alternativen zu erklären sind.
Neue Konzepte, die auf der Integration des Produktgens in das Wirtshromosom basieren,
können die bei Plasmidsystemen auftretenden Instabilitäten und auh die mit Plas-
midreplikation und Expression der Begleitproteine verbundene Stowehselbelastung re-
duzieren. Eine stabile Prozessführung und höhere Produktausbeuten als bei Plasmidsys-
temen sprehen für eine Etablierung der hromosomalen Systeme als industrielle Produk-
tionsprozesse. Jedoh existieren noh wenig Forshungsdaten und Produktionserfahrungen.
Die Erforshung der Produktionskapazitäten eines genomintegrierten Expressionssystems
und die Festlegung der metabolishen Belastungsgrenzen sind von besonderem Interesse
und Wihtigkeit.
Da die rekombinante Genexpression eines integrierten Gens den Wirtszellmetabolismus
niht vollständig auslastet, sollen im Zuge dieser Arbeit zwei idente Kopien des Produk-
tgens ins Wirtshromosom integriert werden. Die Produktionsfähigkeit des Wirtsstamm
sollte durh die Quantizierung des produzierten Proteins ermittelt werden. Der Vergleih
von Fermentationen des einfah genomintegrierten Stammes mit dem doppelt integrierten
Stamm sollte möglihe Produktsteigerungen oder Prozesslimitierungen zeigen.
Weiters stellt die Verfügbarkeit von genomintegrierten Systemen die Voraussetzung für die
Erforshung der metabolishen Belastung verursaht durh Plasmidreplikation und Plasmid
odierte Proteinexpression dar.
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